{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:55:07Z","timestamp":1790618107933,"version":"4.1.0"},"reference-count":268,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Natural Science Foundation of Zhejiang Chinese Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"DOI":"10.1007\/s13679-026-00722-7","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:28:16Z","timestamp":1780712896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergistic Intervention for Obesity: Integrating Central Appetite Regulation and Peripheral Energy Expenditure"],"prefix":"10.1007","volume":"15","author":[{"given":"Jiayan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"10431","key":"722_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/s0140-6736(23)02750-2","volume":"403","author":"Worldwide trends in underweight and obesity","year":"2024","unstructured":"Worldwide trends in underweight and obesity. from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027\u201350. https:\/\/doi.org\/10.1016\/s0140-6736(23)02750-2.","journal-title":"Lancet"},{"issue":"10481","key":"722_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/s0140-6736(25)00355-1","volume":"405","author":"regional Global","year":"2025","unstructured":"Global regional. national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405(10481):813\u201338. https:\/\/doi.org\/10.1016\/s0140-6736(25)00355-1.","journal-title":"Lancet"},{"issue":"18","key":"722_CR3","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/cvr\/cvac176","volume":"119","author":"D Papamargaritis","year":"2024","unstructured":"Papamargaritis D, le Roux CW, Holst JJ, Davies MJ. New therapies for obesity. Cardiovasc Res. 2024;119(18):2825\u201342. https:\/\/doi.org\/10.1093\/cvr\/cvac176.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"722_CR4","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/ajcn\/nqaa220","volume":"112","author":"C Martins","year":"2020","unstructured":"Martins C, Roekenes J, Salamati S, Gower BA, Hunter GR. Metabolic adaptation is an illusion, only present when participants are in negative energy balance. Am J Clin Nutr. 2020;112(5):1212\u20138. https:\/\/doi.org\/10.1093\/ajcn\/nqaa220.","journal-title":"Am J Clin Nutr"},{"key":"722_CR5","doi-asserted-by":"publisher","unstructured":"Flanagan EW, Spann R, Berry SE, Berthoud HR, Broyles S, Foster GD, Krakoff J, Loos RJF, Lowe MR, Ostendorf DM et al. New insights in the mechanisms of weight-loss maintenance: Summary from a Pennington symposium. Obesity (Silver Spring). 2023; 31(12):2895\u20132908.https:\/\/doi.org\/10.1002\/oby.23905","DOI":"10.1002\/oby.23905"},{"issue":"20","key":"722_CR6","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity Management in Adults: A Review. JAMA. 2023;330(20):2000\u201315. https:\/\/doi.org\/10.1001\/jama.2023.19897.","journal-title":"JAMA"},{"issue":"1","key":"722_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40168-022-01264-5","volume":"10","author":"J M\u00fcnzker","year":"2022","unstructured":"M\u00fcnzker J, Haase N, Till A, Sucher R, Haange SB, Nemetschke L, Gnad T, J\u00e4ger E, Chen J, Riede SJ, et al. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity. Microbiome. 2022;10(1):96. https:\/\/doi.org\/10.1186\/s40168-022-01264-5.","journal-title":"Microbiome"},{"issue":"1","key":"722_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1210\/endrev\/bnab022","volume":"43","author":"E Akalestou","year":"2022","unstructured":"Akalestou E, Miras AD, Rutter GA, le Roux CW. Mechanisms of Weight Loss After Obesity Surgery. Endocr Rev. 2022;43(1):19\u201334. https:\/\/doi.org\/10.1210\/endrev\/bnab022.","journal-title":"Endocr Rev"},{"issue":"6","key":"722_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa2301972","volume":"389","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff AM, Kaplan LM, Fr\u00edas JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. N Engl J Med. 2023;389(6):514\u201326. https:\/\/doi.org\/10.1056\/NEJMoa2301972.","journal-title":"N Engl J Med"},{"issue":"4","key":"722_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/febs.15791","volume":"289","author":"NK Smith","year":"2022","unstructured":"Smith NK, Grueter BA. Hunger-driven adaptive prioritization of behavior. Febs j. 2022;289(4):922\u201336. https:\/\/doi.org\/10.1111\/febs.15791.","journal-title":"Febs j"},{"issue":"6665","key":"722_CR11","doi-asserted-by":"publisher","first-page":"eabl7398","DOI":"10.1126\/science.abl7398","volume":"381","author":"JC Br\u00fcning","year":"2023","unstructured":"Br\u00fcning JC, Fenselau H. Integrative neurocircuits that control metabolism and food intake. Science. 2023;381(6665):eabl7398. https:\/\/doi.org\/10.1126\/science.abl7398.","journal-title":"Science"},{"issue":"2","key":"722_CR12","first-page":"123","volume":"24","author":"BK Anand","year":"1951","unstructured":"Anand BK, Brobeck JR. Hypothalamic control of food intake in rats and cats. Yale J Biol Med. 1951;24(2):123\u201340.","journal-title":"Yale J Biol Med"},{"issue":"1","key":"722_CR13","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1038\/s41467-020-20093-4","volume":"11","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen D, Sweeney P, Yang Y. An excitatory ventromedial hypothalamus to paraventricular thalamus circuit that suppresses food intake. Nat Commun. 2020;11(1):6326. https:\/\/doi.org\/10.1038\/s41467-020-20093-4.","journal-title":"Nat Commun"},{"issue":"10","key":"722_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s42255-021-00467-8","volume":"3","author":"E Milbank","year":"2021","unstructured":"Milbank E, Dragano NRV, Gonz\u00e1lez-Garc\u00eda I, Garcia MR, Rivas-Limeres V, Perdomo L, Hilairet G, Ruiz-Pino F, Mallegol P, Morgan DA, et al. Small extracellular vesicle-mediated targeting of hypothalamic AMPK\u03b11 corrects obesity through BAT activation. Nat Metab. 2021;3(10):1415\u201331. https:\/\/doi.org\/10.1038\/s42255-021-00467-8.","journal-title":"Nat Metab"},{"key":"722_CR15","doi-asserted-by":"publisher","unstructured":"Milbank E, Dragano N, Vidal-G\u00f3mez X, Rivas-Limeres V, Garrido-Gil P, Wertheimer M, Recoquillon S, Pata MP, Labandeira-Garcia JL, Di\u00e9guez C, et al. Small extracellular vesicle targeting of hypothalamic AMPK\u03b11 promotes weight loss in leptin receptor deficient mice. Metabolism. 2023;139155350. https:\/\/doi.org\/10.1016\/j.metabol.2022.155350.","DOI":"10.1016\/j.metabol.2022.155350"},{"issue":"4","key":"722_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2012.02.066","volume":"149","author":"AJ Whittle","year":"2012","unstructured":"Whittle AJ, Carobbio S, Martins L, Slawik M, Hondares E, V\u00e1zquez MJ, Morgan D, Csikasz RI, Gallego R, Rodriguez-Cuenca S, et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell. 2012;149(4):871\u201385. https:\/\/doi.org\/10.1016\/j.cell.2012.02.066.","journal-title":"Cell"},{"issue":"8","key":"722_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.celrep.2016.07.045","volume":"16","author":"L Martins","year":"2016","unstructured":"Martins L, Seoane-Collazo P, Contreras C, Gonz\u00e1lez-Garc\u00eda I, Mart\u00ednez-S\u00e1nchez N, Gonz\u00e1lez F, Zalvide J, Gallego R, Di\u00e9guez C, Nogueiras R, et al. A Functional Link between AMPK and Orexin Mediates the Effect of BMP8B on Energy Balance. Cell Rep. 2016;16(8):2231\u201342. https:\/\/doi.org\/10.1016\/j.celrep.2016.07.045.","journal-title":"Cell Rep"},{"issue":"1","key":"722_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2014.03.031","volume":"20","author":"PB Mart\u00ednez de Morentin","year":"2014","unstructured":"Mart\u00ednez de Morentin PB, Gonz\u00e1lez-Garc\u00eda I, Martins L, Lage R, Fern\u00e1ndez-Mallo D, Mart\u00ednez-S\u00e1nchez N, Ru\u00edz-Pino F, Liu J, Morgan DA, Pinilla L, et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 2014;20(1):41\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2014.03.031.","journal-title":"Cell Metab"},{"issue":"1","key":"722_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cmet.2017.06.014","volume":"26","author":"N Mart\u00ednez-S\u00e1nchez","year":"2017","unstructured":"Mart\u00ednez-S\u00e1nchez N, Seoane-Collazo P, Contreras C, Varela L, Villarroya J, Rial-Pensado E, Buqu\u00e9 X, Aurrekoetxea I, Delgado TC, V\u00e1zquez-Mart\u00ednez R, et al. Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance. Cell Metab. 2017;26(1):212\u201329. https:\/\/doi.org\/10.1016\/j.cmet.2017.06.014.","journal-title":"Cell Metab"},{"issue":"9","key":"722_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nm.2207","volume":"16","author":"M L\u00f3pez","year":"2010","unstructured":"L\u00f3pez M, Varela L, V\u00e1zquez MJ, Rodr\u00edguez-Cuenca S, Gonz\u00e1lez CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010;16(9):1001\u20138. https:\/\/doi.org\/10.1038\/nm.2207.","journal-title":"Nat Med"},{"key":"722_CR21","doi-asserted-by":"publisher","first-page":"11395","DOI":"10.1038\/ncomms11395","volume":"7","author":"JA Gonz\u00e1lez","year":"2016","unstructured":"Gonz\u00e1lez JA, Iordanidou P, Strom M, Adamantidis A, Burdakov D. Awake dynamics and brain-wide direct inputs of hypothalamic MCH and orexin networks. Nat Commun. 2016;7:11395. https:\/\/doi.org\/10.1038\/ncomms11395.","journal-title":"Nat Commun"},{"issue":"1","key":"722_CR22","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41467-023-37344-9","volume":"14","author":"KS Subramanian","year":"2023","unstructured":"Subramanian KS, Lauer LT, Hayes AMR, D\u00e9carie-Spain L, McBurnett K, Nourbash AC, Donohue KN, Kao AE, Bashaw AG, Burdakov D, et al. Hypothalamic melanin-concentrating hormone neurons integrate food-motivated appetitive and consummatory processes in rats. Nat Commun. 2023;14(1):1755. https:\/\/doi.org\/10.1038\/s41467-023-37344-9.","journal-title":"Nat Commun"},{"issue":"18","key":"722_CR23","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1016\/j.cub.2016.07.013","volume":"26","author":"JA Gonz\u00e1lez","year":"2016","unstructured":"Gonz\u00e1lez JA, Jensen LT, Iordanidou P, Strom M, Fugger L, Burdakov D. Inhibitory Interplay between Orexin Neurons and Eating. Curr Biol. 2016;26(18):2486\u201391. https:\/\/doi.org\/10.1016\/j.cub.2016.07.013.","journal-title":"Curr Biol"},{"issue":"1","key":"722_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cmet.2008.10.010","volume":"9","author":"H Funato","year":"2009","unstructured":"Funato H, Tsai AL, Willie JT, Kisanuki Y, Williams SC, Sakurai T, Yanagisawa M. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 2009;9(1):64\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2008.10.010.","journal-title":"Cell Metab"},{"issue":"9","key":"722_CR25","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/s41593-024-01696-2","volume":"27","author":"AL Tesmer","year":"2024","unstructured":"Tesmer AL, Li X, Bracey E, Schmandt C, Polania R, Peleg-Raibstein D, Burdakov D. Orexin neurons mediate temptation-resistant voluntary exercise. Nat Neurosci. 2024;27(9):1774\u201382. https:\/\/doi.org\/10.1038\/s41593-024-01696-2.","journal-title":"Nat Neurosci"},{"issue":"4","key":"722_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s0896-6273(01)80035-0","volume":"23","author":"CF Elias","year":"1999","unstructured":"Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron. 1999;23(4):775\u201386. https:\/\/doi.org\/10.1016\/s0896-6273(01)80035-0.","journal-title":"Neuron"},{"issue":"8041","key":"722_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-024-08108-2","volume":"636","author":"HL Tan","year":"2024","unstructured":"Tan HL, Yin L, Tan Y, Ivanov J, Plucinska K, Ilanges A, Herb BR, Wang P, Kosse C, Cohen P, et al. Leptin-activated hypothalamic BNC2 neurons acutely suppress food intake. Nature. 2024;636(8041):198\u2013205. https:\/\/doi.org\/10.1038\/s41586-024-08108-2.","journal-title":"Nature"},{"issue":"3","key":"722_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s42255-024-00987-z","volume":"6","author":"AJ De Solis","year":"2024","unstructured":"De Solis AJ, Del R\u00edo-Mart\u00edn A, Radermacher J, Chen W, Steuernagel L, Bauder CA, Eggersmann FR, Morgan DA, Cremer AL, Su\u00e9 M, et al. Reciprocal activity of AgRP and POMC neurons governs coordinated control of feeding and metabolism. Nat Metab. 2024;6(3):473\u201393. https:\/\/doi.org\/10.1038\/s42255-024-00987-z.","journal-title":"Nat Metab"},{"key":"722_CR29","doi-asserted-by":"publisher","first-page":"174611","DOI":"10.1016\/j.ejphar.2021.174611","volume":"915","author":"MS Vohra","year":"2022","unstructured":"Vohra MS, Benchoula K, Serpell CJ, Hwa WE. AgRP\/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity. Eur J Pharmacol. 2022;915:174611. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174611.","journal-title":"Eur J Pharmacol"},{"issue":"8044","key":"722_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-08164-8","volume":"637","author":"SX Zhang","year":"2025","unstructured":"Zhang SX, Kim A, Madara JC, Zhu PK, Christenson LF, Lutas A, Kalugin PN, Sunkavalli PS, Jin Y, Pal A, et al. Stochastic neuropeptide signals compete to calibrate the rate of satiation. Nature. 2025;637(8044):137\u201344. https:\/\/doi.org\/10.1038\/s41586-024-08164-8.","journal-title":"Nature"},{"key":"722_CR31","doi-asserted-by":"publisher","first-page":"101986","DOI":"10.1016\/j.molmet.2024.101986","volume":"87","author":"RP Reynolds","year":"2024","unstructured":"Reynolds RP, Fan RR, Tinajero A, Luo X, Huen SC, Fujikawa T, Lee S, Lemoff A, Mountjoy KG, Elmquist JK. Alpha-melanocyte-stimulating hormone contributes to an anti-inflammatory response to lipopolysaccharide. Mol Metab. 2024;87:101986. https:\/\/doi.org\/10.1016\/j.molmet.2024.101986.","journal-title":"Mol Metab"},{"issue":"4","key":"722_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/dom.14618","volume":"24","author":"MT Fatima","year":"2022","unstructured":"Fatima MT, Ahmed I, Fakhro KA, Akil ASA. Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies. Diabetes Obes Metab. 2022;24(4):583\u201398. https:\/\/doi.org\/10.1111\/dom.14618.","journal-title":"Diabetes Obes Metab"},{"issue":"6735","key":"722_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.adp1510","volume":"387","author":"M Min\u00e8re","year":"2025","unstructured":"Min\u00e8re M, Wilhelms H, Kuzmanovic B, Lundh S, Fusca D, Cla\u00dfen A, Shtiglitz S, Prilutski Y, Talpir I, Tian L, et al. Thalamic opioids from POMC satiety neurons switch on sugar appetite. Science. 2025;387(6735):750\u20138. https:\/\/doi.org\/10.1126\/science.adp1510.","journal-title":"Science"},{"issue":"1","key":"722_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41467-020-14291-3","volume":"11","author":"L Engstr\u00f6m Ruud","year":"2020","unstructured":"Engstr\u00f6m Ruud L, Pereira MMA, de Solis AJ, Fenselau H, Br\u00fcning JC. NPY mediates the rapid feeding and glucose metabolism regulatory functions of AgRP neurons. Nat Commun. 2020;11(1):442. https:\/\/doi.org\/10.1038\/s41467-020-14291-3.","journal-title":"Nat Commun"},{"issue":"4","key":"722_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.cmet.2013.09.009","volume":"18","author":"MJ Krashes","year":"2013","unstructured":"Krashes MJ, Shah BP, Koda S, Lowell BB. Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab. 2013;18(4):588\u201395. https:\/\/doi.org\/10.1016\/j.cmet.2013.09.009.","journal-title":"Cell Metab"},{"key":"722_CR36","doi-asserted-by":"publisher","unstructured":"Xie D, Stutz B, Li F, Chen F, Lv H, Sestan-Pesa M, Catarino J, Gu J, Zhao H, Stoddard CE et al. TET3 epigenetically controls feeding and stress response behaviors via AGRP neurons. J Clin Invest. 2022; 132(19). https:\/\/doi.org\/10.1172\/jci162365","DOI":"10.1172\/jci162365"},{"issue":"10","key":"722_CR37","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1016\/j.celrep.2017.11.036","volume":"21","author":"Z Su","year":"2017","unstructured":"Su Z, Alhadeff AL, Betley JN. Nutritive, Post-ingestive Signals Are the Primary Regulators of AgRP Neuron Activity. Cell Rep. 2017;21(10):2724\u201336. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.036.","journal-title":"Cell Rep"},{"issue":"5","key":"722_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2015.01.033","volume":"160","author":"Y Chen","year":"2015","unstructured":"Chen Y, Lin YC, Kuo TW, Knight ZA. Sensory detection of food rapidly modulates arcuate feeding circuits. Cell. 2015;160(5):829\u201341. https:\/\/doi.org\/10.1016\/j.cell.2015.01.033.","journal-title":"Cell"},{"issue":"7869","key":"722_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-021-03729-3","volume":"595","author":"J Berrios","year":"2021","unstructured":"Berrios J, Li C, Madara JC, Garfield AS, Steger JS, Krashes MJ, Lowell BB. Food cue regulation of AGRP hunger neurons guides learning. Nature. 2021;595(7869):695\u2013700. https:\/\/doi.org\/10.1038\/s41586-021-03729-3.","journal-title":"Nature"},{"issue":"3","key":"722_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cmet.2020.12.018","volume":"33","author":"N Goldstein","year":"2021","unstructured":"Goldstein N, McKnight AD, Carty JRE, Arnold M, Betley JN, Alhadeff AL. Hypothalamic detection of macronutrients via multiple gut-brain pathways. Cell Metab. 2021;33(3):676\u201387. https:\/\/doi.org\/10.1016\/j.cmet.2020.12.018.","journal-title":"Cell Metab"},{"issue":"3","key":"722_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cmet.2024.11.009","volume":"37","author":"AM Douglass","year":"2025","unstructured":"Douglass AM, Kucukdereli H, Madara JC, Wang D, Wu C, Lowenstein ED, Tao J, Lowell BB. Acute and circadian feedforward regulation of agouti-related peptide hunger neurons. Cell Metab. 2025;37(3):708\u201322. https:\/\/doi.org\/10.1016\/j.cmet.2024.11.009.","journal-title":"Cell Metab"},{"issue":"6","key":"722_CR42","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2020.03.022","volume":"106","author":"A Jais","year":"2020","unstructured":"Jais A, Paeger L, Sotelo-Hitschfeld T, Bremser S, Prinzensteiner M, Klemm P, Mykytiuk V, Widdershooven PJM, Vesting AJ, Grzelka K, et al. PNOC(ARC) Neurons Promote Hyperphagia and Obesity upon High-Fat-Diet Feeding. Neuron. 2020;106(6):1009\u201325. https:\/\/doi.org\/10.1016\/j.neuron.2020.03.022.","journal-title":"Neuron"},{"issue":"1","key":"722_CR43","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.1038\/s41467-024-53258-6","volume":"15","author":"M Xing","year":"2024","unstructured":"Xing M, Li Y, Zhang Y, Zhou J, Ma D, Zhang M, Tang M, Ouyang T, Zhang F, Shi X, et al. Paraventricular hypothalamic RUVBL2 neurons suppress appetite by enhancing excitatory synaptic transmission in distinct neurocircuits. Nat Commun. 2024;15(1):8939. https:\/\/doi.org\/10.1038\/s41467-024-53258-6.","journal-title":"Nat Commun"},{"issue":"2","key":"722_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cmet.2019.12.012","volume":"31","author":"W Cheng","year":"2020","unstructured":"Cheng W, Gonzalez I, Pan W, Tsang AH, Adams J, Ndoka E, Gordian D, Khoury B, Roelofs K, Evers SS, et al. Calcitonin Receptor Neurons in the Mouse Nucleus Tractus Solitarius Control Energy Balance via the Non-aversive Suppression of Feeding. Cell Metab. 2020;31(2):301\u201312. https:\/\/doi.org\/10.1016\/j.cmet.2019.12.012.","journal-title":"Cell Metab"},{"issue":"1","key":"722_CR45","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1038\/s41467-021-25525-3","volume":"12","author":"W Cheng","year":"2021","unstructured":"Cheng W, Ndoka E, Maung JN, Pan W, Rupp AC, Rhodes CJ, Olson DP, Myers MG Jr. NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity. Nat Commun. 2021;12(1):5175. https:\/\/doi.org\/10.1038\/s41467-021-25525-3.","journal-title":"Nat Commun"},{"key":"722_CR46","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85640","author":"W Qiu","year":"2023","unstructured":"Qiu W, Hutch CR, Wang Y, Wloszek J, Rucker RA, Myers MG, Sandoval D. Multiple NTS neuron populations cumulatively suppress food intake. Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.85640.","journal-title":"Elife"},{"issue":"17\u201320","key":"722_CR47","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1101\/gad.352276.124","volume":"38","author":"D van de Lisdonk","year":"2024","unstructured":"van de Lisdonk D, Li B. The area postrema: a critical mediator of brain-body interactions. Genes Dev. 2024;38(17\u201320):793\u20137. https:\/\/doi.org\/10.1101\/gad.352276.124.","journal-title":"Genes Dev"},{"key":"722_CR48","doi-asserted-by":"publisher","unstructured":"Beutler LR. GLP-1 physiology and pharmacology along the gut-brain axis. J Clin Invest. 2026;136(2). https:\/\/doi.org\/10.1172\/jci194744.","DOI":"10.1172\/jci194744"},{"issue":"4","key":"722_CR49","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","volume":"3","author":"MQ Ludwig","year":"2021","unstructured":"Ludwig MQ, Cheng W, Gordian D, Lee J, Paulsen SJ, Hansen SN, Egerod KL, Barkholt P, Rhodes CJ, Secher A, et al. A genetic map of the mouse dorsal vagal complex and its role in obesity. Nat Metab. 2021;3(4):530\u201345. https:\/\/doi.org\/10.1038\/s42255-021-00363-1.","journal-title":"Nat Metab"},{"issue":"3","key":"722_CR50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","volume":"109","author":"C Zhang","year":"2021","unstructured":"Zhang C, Kaye JA, Cai Z, Wang Y, Prescott SL, Liberles SD. Area Postrema Cell Types that Mediate Nausea-Associated Behaviors. Neuron. 2021;109(3):461\u201372. https:\/\/doi.org\/10.1016\/j.neuron.2020.11.010.","journal-title":"Neuron"},{"issue":"13","key":"722_CR51","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMra2500106","volume":"394","author":"CJ Rosen","year":"2026","unstructured":"Rosen CJ, Ingelfinger JR. GLP-1 Receptor Agonists. N Engl J Med. 2026;394(13):1313\u201324. https:\/\/doi.org\/10.1056\/NEJMra2500106.","journal-title":"N Engl J Med"},{"issue":"8025","key":"722_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","volume":"632","author":"KP Huang","year":"2024","unstructured":"Huang KP, Acosta AA, Ghidewon MY, McKnight AD, Almeida MS, Nyema NT, Hanchak ND, Patel N, Gbenou YSK, Adriaenssens AE, et al. Dissociable hindbrain GLP1R circuits for satiety and aversion. Nature. 2024;632(8025):585\u201393. https:\/\/doi.org\/10.1038\/s41586-024-07685-6.","journal-title":"Nature"},{"issue":"8","key":"722_CR53","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s42255-024-01100-0","volume":"6","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang Y, Zhao ZD, Xie G, Zhang C, Chen R, Zhang Y. A subset of dopamine receptor-expressing neurons in the nucleus accumbens controls feeding and energy homeostasis. Nat Metab. 2024;6(8):1616\u201331. https:\/\/doi.org\/10.1038\/s42255-024-01100-0.","journal-title":"Nat Metab"},{"issue":"4","key":"722_CR54","doi-asserted-by":"publisher","first-page":"113990","DOI":"10.1016\/j.celrep.2024.113990","volume":"43","author":"W Ding","year":"2024","unstructured":"Ding W, Weltzien H, Peters C, Klein R. Nausea-induced suppression of feeding is mediated by central amygdala Dlk1-expressing neurons. Cell Rep. 2024;43(4):113990. https:\/\/doi.org\/10.1016\/j.celrep.2024.113990.","journal-title":"Cell Rep"},{"issue":"1","key":"722_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tics.2010.11.001","volume":"15","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011;15(1):37\u201346. https:\/\/doi.org\/10.1016\/j.tics.2010.11.001.","journal-title":"Trends Cogn Sci"},{"issue":"11","key":"722_CR56","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.neuron.2025.03.010","volume":"113","author":"GD Stuber","year":"2025","unstructured":"Stuber GD, Schwitzgebel VM, L\u00fcscher C. The neurobiology of overeating. Neuron. 2025;113(11):1680\u201393. https:\/\/doi.org\/10.1016\/j.neuron.2025.03.010.","journal-title":"Neuron"},{"issue":"6","key":"722_CR57","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.neuron.2016.04.035","volume":"90","author":"EH Nieh","year":"2016","unstructured":"Nieh EH, Vander Weele CM, Matthews GA, Presbrey KN, Wichmann R, Leppla CA, Izadmehr EM, Tye KM. Inhibitory Input from the Lateral Hypothalamus to the Ventral Tegmental Area Disinhibits Dopamine Neurons and Promotes Behavioral Activation. Neuron. 2016;90(6):1286\u201398. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.035.","journal-title":"Neuron"},{"issue":"6741","key":"722_CR58","doi-asserted-by":"publisher","first-page":"eadt0773","DOI":"10.1126\/science.adt0773","volume":"387","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Gong R, Rodriguez V, Quach KT, Chen X, Sternson SM. Hedonic eating is controlled by dopamine neurons that oppose GLP-1R satiety. Science. 2025;387(6741):eadt0773. https:\/\/doi.org\/10.1126\/science.adt0773.","journal-title":"Science"},{"issue":"8065","key":"722_CR59","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41586-025-08748-y","volume":"641","author":"N Gazit Shimoni","year":"2025","unstructured":"Gazit Shimoni N, Tose AJ, Seng C, Jin Y, Lukacsovich T, Yang H, Verharen JPH, Liu C, Tanios M, Hu E, et al. Changes in neurotensin signalling drive hedonic devaluation in obesity. Nature. 2025;641(8065):1238\u201347. https:\/\/doi.org\/10.1038\/s41586-025-08748-y.","journal-title":"Nature"},{"issue":"4","key":"722_CR60","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cmet.2023.02.015","volume":"35","author":"S Edwin Thanarajah","year":"2023","unstructured":"Edwin Thanarajah S, DiFeliceantonio AG, Albus K, Kuzmanovic B, Rigoux L, Iglesias S, Han\u00dfen R, Schlamann M, Cornely OA, Br\u00fcning JC, et al. Habitual daily intake of a sweet and fatty snack modulates reward processing in humans. Cell Metab. 2023;35(4):571\u201384. https:\/\/doi.org\/10.1016\/j.cmet.2023.02.015.","journal-title":"Cell Metab"},{"issue":"2","key":"722_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2023.12.014","volume":"36","author":"M McDougle","year":"2024","unstructured":"McDougle M, de Araujo A, Singh A, Yang M, Braga I, Paille V, Mendez-Hernandez R, Vergara M, Woodie LN, Gour A, et al. Separate gut-brain circuits for fat and sugar reinforcement combine to promote overeating. Cell Metab. 2024;36(2):393\u2013407. https:\/\/doi.org\/10.1016\/j.cmet.2023.12.014.","journal-title":"Cell Metab"},{"issue":"5","key":"722_CR62","doi-asserted-by":"publisher","first-page":"eadz0828","DOI":"10.1126\/sciadv.adz0828","volume":"12","author":"O Onimus","year":"2026","unstructured":"Onimus O, Arrivet F, Le Borgne T, Perez S, Castel J, Ansoult A, Bertrand B, Mashhour N, de Almeida C, Bui LC, et al. The gut-brain vagal axis governs mesolimbic dopamine dynamics and reward events. Sci Adv. 2026;12(5):eadz0828. https:\/\/doi.org\/10.1126\/sciadv.adz0828.","journal-title":"Sci Adv"},{"issue":"7","key":"722_CR63","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.cmet.2021.05.002","volume":"33","author":"D Borgmann","year":"2021","unstructured":"Borgmann D, Ciglieri E, Biglari N, Brandt C, Cremer AL, Backes H, Tittgemeyer M, Wunderlich FT, Br\u00fcning JC, Fenselau H. Gut-brain communication by distinct sensory neurons differently controls feeding and glucose metabolism. Cell Metab. 2021;33(7):1466\u201382. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.002.","journal-title":"Cell Metab"},{"issue":"1","key":"722_CR64","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12967-025-06656-3","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu J, Jing C, Guo Y, Shang Z, Zhang B, Zhou X, Zhang J, Lian G, Tian F, Li L, et al. The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review. J Transl Med. 2025;23(1):648. https:\/\/doi.org\/10.1186\/s12967-025-06656-3.","journal-title":"J Transl Med"},{"issue":"2","key":"722_CR65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364\u201371. https:\/\/doi.org\/10.2337\/db11-1019.","journal-title":"Diabetes"},{"issue":"3","key":"722_CR66","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ijo.2014.153","volume":"39","author":"A Psichas","year":"2015","unstructured":"Psichas A, Sleeth ML, Murphy KG, Brooks L, Bewick GA, Hanyaloglu AC, Ghatei MA, Bloom SR, Frost G. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond). 2015;39(3):424\u20139. https:\/\/doi.org\/10.1038\/ijo.2014.153.","journal-title":"Int J Obes (Lond)"},{"key":"722_CR67","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1038\/ncomms4611","volume":"5","author":"G Frost","year":"2014","unstructured":"Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, Hankir M, Zhang S, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 2014;5:3611. https:\/\/doi.org\/10.1038\/ncomms4611.","journal-title":"Nat Commun"},{"issue":"10","key":"722_CR68","doi-asserted-by":"publisher","first-page":"e0101524","DOI":"10.1128\/msystems.01015-24","volume":"9","author":"S Li","year":"2024","unstructured":"Li S, Liu M, Han Y, Liu C, Cao S, Cui Y, Zhu X, Wang Z, Liu B, Shi Y. Gut microbiota-derived gamma-aminobutyric acid improves host appetite by inhibiting satiety hormone secretion. mSystems. 2024;9(10):e0101524. https:\/\/doi.org\/10.1128\/msystems.01015-24.","journal-title":"mSystems"},{"issue":"6","key":"722_CR69","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","volume":"76","author":"T Li","year":"2024","unstructured":"Li T, Chiang JYL. Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development. Pharmacol Rev. 2024;76(6):1221\u201353. https:\/\/doi.org\/10.1124\/pharmrev.124.000978.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"722_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","volume":"13","author":"C Xing","year":"2023","unstructured":"Xing C, Huang X, Wang D, Yu D, Hou S, Cui H, Song L. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci. 2023;13(1):106. https:\/\/doi.org\/10.1186\/s13578-023-01053-z.","journal-title":"Cell Biosci"},{"issue":"5","key":"722_CR71","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-021-00398-4","volume":"3","author":"A Perino","year":"2021","unstructured":"Perino A, Vel\u00e1zquez-Villegas LA, Bresciani N, Sun Y, Huang Q, F\u00e9nelon VS, Castellanos-Jankiewicz A, Zizzari P, Bruschetta G, Jin S, et al. Central anorexigenic actions of bile acids are mediated by TGR5. Nat Metab. 2021;3(5):595\u2013603. https:\/\/doi.org\/10.1038\/s42255-021-00398-4.","journal-title":"Nat Metab"},{"issue":"7","key":"722_CR72","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cmet.2021.04.009","volume":"33","author":"A Castellanos-Jankiewicz","year":"2021","unstructured":"Castellanos-Jankiewicz A, Guzm\u00e1n-Quevedo O, F\u00e9nelon VS, Zizzari P, Quarta C, Bellocchio L, Tailleux A, Charton J, Fernandois D, Henricsson M, et al. Hypothalamic bile acid-TGR5 signaling protects from obesity. Cell Metab. 2021;33(7):1483\u201392. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.009.","journal-title":"Cell Metab"},{"issue":"1","key":"722_CR73","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1038\/s41467-025-60331-1","volume":"16","author":"K Bruce","year":"2025","unstructured":"Bruce K, Zhang SY, Garrido AN, Wang MT, Bachor TP, Wang P, Xu AW, Yang Z, Lam TKT. Pharmacological and physiological activation of TGR5 in the NTS lowers food intake by enhancing leptin-STAT3 signaling. Nat Commun. 2025;16(1):4990. https:\/\/doi.org\/10.1038\/s41467-025-60331-1.","journal-title":"Nat Commun"},{"issue":"1","key":"722_CR74","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/endrev\/bnz007","volume":"41","author":"C Scheele","year":"2020","unstructured":"Scheele C, Wolfrum C. Brown Adipose Crosstalk in Tissue Plasticity and Human Metabolism. Endocr Rev. 2020;41(1):53\u201365. https:\/\/doi.org\/10.1210\/endrev\/bnz007.","journal-title":"Endocr Rev"},{"issue":"3","key":"722_CR75","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","volume":"185","author":"A Sakers","year":"2022","unstructured":"Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 2022;185(3):419\u201346. https:\/\/doi.org\/10.1016\/j.cell.2021.12.016.","journal-title":"Cell"},{"issue":"15","key":"722_CR76","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","volume":"360","author":"AM Cypess","year":"2009","unstructured":"Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509\u201317. https:\/\/doi.org\/10.1056\/NEJMoa0810780.","journal-title":"N Engl J Med"},{"issue":"2","key":"722_CR77","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","volume":"150","author":"J Wu","year":"2012","unstructured":"Wu J, Bostr\u00f6m P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150(2):366\u201376. https:\/\/doi.org\/10.1016\/j.cell.2012.05.016.","journal-title":"Cell"},{"key":"722_CR78","doi-asserted-by":"publisher","first-page":"10184","DOI":"10.1038\/ncomms10184","volume":"7","author":"DC Berry","year":"2016","unstructured":"Berry DC, Jiang Y, Graff JM. Mouse strains to study cold-inducible beige progenitors and beige adipocyte formation and function. Nat Commun. 2016;7:10184. https:\/\/doi.org\/10.1038\/ncomms10184.","journal-title":"Nat Commun"},{"key":"722_CR79","doi-asserted-by":"publisher","unstructured":"Jiang Y, Berry DC, Graff JM. Distinct cellular and molecular mechanisms for \u03b23 adrenergic receptor-induced beige adipocyte formation. Elife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.30329.","DOI":"10.7554\/eLife.30329"},{"issue":"3","key":"722_CR80","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cell.2020.07.014","volume":"182","author":"CJ Villanueva","year":"2020","unstructured":"Villanueva CJ. Finding a Needle in a Haystack: Identification of a Beige Fat Progenitor. Cell. 2020;182(3):537\u20139. https:\/\/doi.org\/10.1016\/j.cell.2020.07.014.","journal-title":"Cell"},{"issue":"4","key":"722_CR81","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s42255-021-00373-z","volume":"3","author":"F Shamsi","year":"2021","unstructured":"Shamsi F, Piper M, Ho LL, Huang TL, Gupta A, Streets A, Lynes MD, Tseng YH. Vascular smooth muscle-derived Trpv1(+) progenitors are a source of cold-induced thermogenic adipocytes. Nat Metab. 2021;3(4):485\u201395. https:\/\/doi.org\/10.1038\/s42255-021-00373-z.","journal-title":"Nat Metab"},{"issue":"8032","key":"722_CR82","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-024-07863-6","volume":"634","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Yao L, Gallo-Ferraz AL, Bombassaro B, Sim\u00f5es MR, Abe I, Chen J, Sarker G, Ciccarelli A, Zhou L, et al. Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat. Nature. 2024;634(8032):243\u201350. https:\/\/doi.org\/10.1038\/s41586-024-07863-6.","journal-title":"Nature"},{"issue":"1","key":"722_CR83","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1038\/s41467-025-60754-w","volume":"16","author":"Q Chen","year":"2025","unstructured":"Chen Q, Yu Y, Zhang R, Zhao Q, Yu D, Feng C, Zhou J, Luo M, Yang M, Sun S, et al. Commitment of adipose-resident c-kit(+) progenitors to brown adipocytes contributes to adipose tissue homeostasis and remodeling. Nat Commun. 2025;16(1):5883. https:\/\/doi.org\/10.1038\/s41467-025-60754-w.","journal-title":"Nat Commun"},{"issue":"9","key":"722_CR84","doi-asserted-by":"publisher","first-page":"103717","DOI":"10.1016\/j.drudis.2023.103717","volume":"28","author":"U Jagtap","year":"2023","unstructured":"Jagtap U, Paul A. UCP1 activation: Hottest target in the thermogenesis pathway to treat obesity using molecules of synthetic and natural origin. Drug Discov Today. 2023;28(9):103717. https:\/\/doi.org\/10.1016\/j.drudis.2023.103717.","journal-title":"Drug Discov Today"},{"issue":"7972","key":"722_CR85","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41586-023-06332-w","volume":"620","author":"Y Kang","year":"2023","unstructured":"Kang Y, Chen L. Structural basis for the binding of DNP and purine nucleotides onto UCP1. Nature. 2023;620(7972):226\u201331. https:\/\/doi.org\/10.1038\/s41586-023-06332-w.","journal-title":"Nature"},{"key":"722_CR86","doi-asserted-by":"publisher","first-page":"1252141","DOI":"10.3389\/fendo.2023.1252141","volume":"14","author":"G Xiong","year":"2023","unstructured":"Xiong G, Zhang K, Ma Y, Song Y, Zhang W, Qi T, Qiu H, Shi J, Kan C, Zhang J, et al. BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases. Front Endocrinol (Lausanne). 2023;14:1252141. https:\/\/doi.org\/10.3389\/fendo.2023.1252141.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7912","key":"722_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41586-022-04747-5","volume":"606","author":"AM Bertholet","year":"2022","unstructured":"Bertholet AM, Natale AM, Bisignano P, Suzuki J, Fedorenko A, Hamilton J, Brustovetsky T, Kazak L, Garrity R, Chouchani ET, et al. Mitochondrial uncouplers induce proton leak by activating AAC and UCP1. Nature. 2022;606(7912):180\u20137. https:\/\/doi.org\/10.1038\/s41586-022-04747-5.","journal-title":"Nature"},{"issue":"3","key":"722_CR88","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cmet.2024.01.016","volume":"36","author":"M Dong","year":"2024","unstructured":"Dong M, Cheng Z, Jin W. UCP1 and CKB are parallel players in BAT. Cell Metab. 2024;36(3):459\u201360. https:\/\/doi.org\/10.1016\/j.cmet.2024.01.016.","journal-title":"Cell Metab"},{"issue":"3","key":"722_CR89","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cell.2015.09.035","volume":"163","author":"L Kazak","year":"2015","unstructured":"Kazak L, Chouchani ET, Jedrychowski MP, Erickson BK, Shinoda K, Cohen P, Vetrivelan R, Lu GZ, Laznik-Bogoslavski D, Hasenfuss SC, et al. A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat. Cell. 2015;163(3):643\u201355. https:\/\/doi.org\/10.1016\/j.cell.2015.09.035.","journal-title":"Cell"},{"issue":"7846","key":"722_CR90","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41586-021-03221-y","volume":"590","author":"JF Rahbani","year":"2021","unstructured":"Rahbani JF, Roesler A, Hussain MF, Samborska B, Dykstra CB, Tsai L, Jedrychowski MP, Vergnes L, Reue K, Spiegelman BM, et al. Creatine kinase B controls futile creatine cycling in thermogenic fat. Nature. 2021;590(7846):480\u20135. https:\/\/doi.org\/10.1038\/s41586-021-03221-y.","journal-title":"Nature"},{"issue":"7860","key":"722_CR91","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-021-03533-z","volume":"593","author":"Y Sun","year":"2021","unstructured":"Sun Y, Rahbani JF, Jedrychowski MP, Riley CL, Vidoni S, Bogoslavski D, Hu B, Dumesic PA, Zeng X, Wang AB, et al. Mitochondrial TNAP controls thermogenesis by hydrolysis of phosphocreatine. Nature. 2021;593(7860):580\u20135. https:\/\/doi.org\/10.1038\/s41586-021-03533-z.","journal-title":"Nature"},{"issue":"6\u20137","key":"722_CR92","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bbabio.2010.04.016","volume":"1797","author":"AE Adams","year":"2010","unstructured":"Adams AE, Kelly OM, Porter RK. Absence of mitochondrial uncoupling protein 1 affects apoptosis in thymocytes, thymocyte\/T-cell profile and peripheral T-cell number. Biochim Biophys Acta. 2010;1797(6\u20137):807\u201316. https:\/\/doi.org\/10.1016\/j.bbabio.2010.04.016.","journal-title":"Biochim Biophys Acta"},{"issue":"30","key":"722_CR93","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1073\/pnas.1705406114","volume":"114","author":"L Kazak","year":"2017","unstructured":"Kazak L, Chouchani ET, Stavrovskaya IG, Lu GZ, Jedrychowski MP, Egan DF, Kumari M, Kong X, Erickson BK, Szpyt J, et al. UCP1 deficiency causes brown fat respiratory chain depletion and sensitizes mitochondria to calcium overload-induced dysfunction. Proc Natl Acad Sci U S A. 2017;114(30):7981\u20136. https:\/\/doi.org\/10.1073\/pnas.1705406114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"722_CR94","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cmet.2024.01.001","volume":"36","author":"JF Rahbani","year":"2024","unstructured":"Rahbani JF, Bunk J, Lagarde D, Samborska B, Roesler A, Xiao H, Shaw A, Kaiser Z, Braun JL, Geromella MS, et al. Parallel control of cold-triggered adipocyte thermogenesis by UCP1 and CKB. Cell Metab. 2024;36(3):526\u201340. https:\/\/doi.org\/10.1016\/j.cmet.2024.01.001.","journal-title":"Cell Metab"},{"key":"722_CR95","doi-asserted-by":"publisher","first-page":"101499","DOI":"10.1016\/j.molmet.2022.101499","volume":"61","author":"J Oeckl","year":"2022","unstructured":"Oeckl J, Janovska P, Adamcova K, Bardova K, Brunner S, Dieckmann S, Ecker J, Fromme T, Funda J, Gantert T, et al. Loss of UCP1 function augments recruitment of futile lipid cycling for thermogenesis in murine brown fat. Mol Metab. 2022;61:101499. https:\/\/doi.org\/10.1016\/j.molmet.2022.101499.","journal-title":"Mol Metab"},{"issue":"4","key":"722_CR96","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1152\/physrev.00024.2024","volume":"105","author":"P Poursharifi","year":"2025","unstructured":"Poursharifi P, Madiraju SRM, Oppong A, Kajimura S, Nolan CJ, Blondin DP, Prentki M. Glycerolipid Cycling in Thermogenesis, Energy Homeostasis, Signaling, and Diseases. Physiol Rev. 2025;105(4):2449\u201399. https:\/\/doi.org\/10.1152\/physrev.00024.2024.","journal-title":"Physiol Rev"},{"issue":"12","key":"722_CR97","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/nm.4429","volume":"23","author":"K Ikeda","year":"2017","unstructured":"Ikeda K, Kang Q, Yoneshiro T, Camporez JP, Maki H, Homma M, Shinoda K, Chen Y, Lu X, Maretich P, et al. UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis. Nat Med. 2017;23(12):1454\u201365. https:\/\/doi.org\/10.1038\/nm.4429.","journal-title":"Nat Med"},{"issue":"6","key":"722_CR98","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cmet.2025.03.009","volume":"37","author":"C Auger","year":"2025","unstructured":"Auger C, Li M, Fujimoto M, Ikeda K, Yook JS, O\u2019Leary TR, Caycedo MPH, Xiaohan C, Oikawa S, Verkerke ARP, et al. Identification of a molecular resistor that controls UCP1-independent Ca(2+) cycling thermogenesis in adipose tissue. Cell Metab. 2025;37(6):1311\u201325. https:\/\/doi.org\/10.1016\/j.cmet.2025.03.009.","journal-title":"Cell Metab"},{"issue":"1","key":"722_CR99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1152\/physrev.00005.2006","volume":"87","author":"J Satr\u00fastegui","year":"2007","unstructured":"Satr\u00fastegui J, Pardo B, Del Arco A. Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev. 2007;87(1):29\u201367. https:\/\/doi.org\/10.1152\/physrev.00005.2006.","journal-title":"Physiol Rev"},{"issue":"11","key":"722_CR100","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbabio.2009.01.005","volume":"1787","author":"RM Denton","year":"2009","unstructured":"Denton RM. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim Biophys Acta. 2009;1787(11):1309\u201316. https:\/\/doi.org\/10.1016\/j.bbabio.2009.01.005.","journal-title":"Biochim Biophys Acta"},{"issue":"7360","key":"722_CR101","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature10230","volume":"476","author":"D De Stefani","year":"2011","unstructured":"De Stefani D, Raffaello A, Teardo E, Szab\u00f2 I, Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature. 2011;476(7360):336\u201340. https:\/\/doi.org\/10.1038\/nature10230.","journal-title":"Nature"},{"issue":"3","key":"722_CR102","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tcb.2022.11.008","volume":"33","author":"K Xue","year":"2023","unstructured":"Xue K, Wu D, Qiu Y. Thermoporter: a new regulatory mechanism for mitochondrial calcium uniporter activity. Trends Cell Biol. 2023;33(3):182\u20134. https:\/\/doi.org\/10.1016\/j.tcb.2022.11.008.","journal-title":"Trends Cell Biol"},{"issue":"9","key":"722_CR103","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.cmet.2022.07.011","volume":"34","author":"K Xue","year":"2022","unstructured":"Xue K, Wu D, Wang Y, Zhao Y, Shen H, Yao J, Huang X, Li X, Zhou Z, Wang Z, et al. The mitochondrial calcium uniporter engages UCP1 to form a thermoporter that promotes thermogenesis. Cell Metab. 2022;34(9):1325\u201341. https:\/\/doi.org\/10.1016\/j.cmet.2022.07.011.","journal-title":"Cell Metab"},{"issue":"8087","key":"722_CR104","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41586-025-09517-7","volume":"646","author":"X Liu","year":"2025","unstructured":"Liu X, He A, Lu D, Hu D, Tan M, Abere A, Goodarzi P, Ahmad B, Kleiboeker B, Finck BN, et al. Peroxisomal metabolism of branched fatty acids regulates energy homeostasis. Nature. 2025;646(8087):1223\u201331. https:\/\/doi.org\/10.1038\/s41586-025-09517-7.","journal-title":"Nature"},{"issue":"7375","key":"722_CR105","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature10653","volume":"480","author":"KD Nguyen","year":"2011","unstructured":"Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, Mukundan L, Brombacher F, Locksley RM, Chawla A. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature. 2011;480(7375):104\u20138. https:\/\/doi.org\/10.1038\/nature10653.","journal-title":"Nature"},{"issue":"6","key":"722_CR106","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.cell.2014.03.066","volume":"157","author":"Y Qiu","year":"2014","unstructured":"Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM, Palmiter RD, Chawla A. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell. 2014;157(6):1292\u2013308. https:\/\/doi.org\/10.1016\/j.cell.2014.03.066.","journal-title":"Cell"},{"issue":"6","key":"722_CR107","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.cell.2014.05.025","volume":"157","author":"SD Lee","year":"2014","unstructured":"Lee SD, Tontonoz P. Eosinophils in fat: pink is the new brown. Cell. 2014;157(6):1249\u201350. https:\/\/doi.org\/10.1016\/j.cell.2014.05.025.","journal-title":"Cell"},{"issue":"11","key":"722_CR108","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s42255-021-00482-9","volume":"3","author":"YN Wang","year":"2021","unstructured":"Wang YN, Tang Y, He Z, Ma H, Wang L, Liu Y, Yang Q, Pan D, Zhu C, Qian S, et al. Slit3 secreted from M2-like macrophages increases sympathetic activity and thermogenesis in adipose tissue. Nat Metab. 2021;3(11):1536\u201351. https:\/\/doi.org\/10.1038\/s42255-021-00482-9.","journal-title":"Nat Metab"},{"issue":"1","key":"722_CR109","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/s41467-024-45899-4","volume":"15","author":"S Wu","year":"2024","unstructured":"Wu S, Qiu C, Ni J, Guo W, Song J, Yang X, Sun Y, Chen Y, Zhu Y, Chang X, et al. M2 macrophages independently promote beige adipogenesis via blocking adipocyte Ets1. Nat Commun. 2024;15(1):1646. https:\/\/doi.org\/10.1038\/s41467-024-45899-4.","journal-title":"Nat Commun"},{"issue":"1","key":"722_CR110","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41467-020-20665-4","volume":"12","author":"H Zhou","year":"2021","unstructured":"Zhou H, Peng X, Hu J, Wang L, Luo H, Zhang J, Zhang Y, Li G, Ji Y, Zhang J, et al. DsbA-L deficiency in T cells promotes diet-induced thermogenesis through suppressing IFN-\u03b3 production. Nat Commun. 2021;12(1):326. https:\/\/doi.org\/10.1038\/s41467-020-20665-4.","journal-title":"Nat Commun"},{"issue":"109","key":"722_CR111","doi-asserted-by":"publisher","first-page":"eads0478","DOI":"10.1126\/sciimmunol.ads0478","volume":"10","author":"NW Zammit","year":"2025","unstructured":"Zammit NW, Vargas-Castillo A, Langston PK, Wang G, Zhou Y, Spiegelman BM, Benoist C, Mathis D. Regulatory T cells in brown adipose tissue safeguard thermogenesis by restraining interferon-\u03b3-producing lymphocytes. Sci Immunol. 2025;10(109):eads0478. https:\/\/doi.org\/10.1126\/sciimmunol.ads0478.","journal-title":"Sci Immunol"},{"issue":"3","key":"722_CR112","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cmet.2016.08.003","volume":"24","author":"L Lynch","year":"2016","unstructured":"Lynch L, Hogan AE, Duquette D, Lester C, Banks A, LeClair K, Cohen DE, Ghosh A, Lu B, Corrigan M, et al. iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy. Cell Metab. 2016;24(3):510\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.003.","journal-title":"Cell Metab"},{"issue":"7796","key":"722_CR113","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41586-020-2028-z","volume":"578","author":"B Hu","year":"2020","unstructured":"Hu B, Jin C, Zeng X, Resch JM, Jedrychowski MP, Yang Z, Desai BN, Banks AS, Lowell BB, Mathis D, et al. \u03b3\u03b4 T cells and adipocyte IL-17RC control fat innervation and thermogenesis. Nature. 2020;578(7796):610\u20134. https:\/\/doi.org\/10.1038\/s41586-020-2028-z.","journal-title":"Nature"},{"issue":"7888","key":"722_CR114","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41586-021-04127-5","volume":"600","author":"Q Wang","year":"2021","unstructured":"Wang Q, Li D, Cao G, Shi Q, Zhu J, Zhang M, Cheng H, Wen Q, Xu H, Zhu L, et al. IL-27 signalling promotes adipocyte thermogenesis and energy expenditure. Nature. 2021;600(7888):314\u20138. https:\/\/doi.org\/10.1038\/s41586-021-04127-5.","journal-title":"Nature"},{"issue":"10","key":"722_CR115","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/j.celrep.2019.02.015","volume":"26","author":"B Li","year":"2019","unstructured":"Li B, Li L, Li M, Lam SM, Wang G, Wu Y, Zhang H, Niu C, Zhang X, Liu X, et al. Microbiota Depletion Impairs Thermogenesis of Brown Adipose Tissue and Browning of White Adipose Tissue. Cell Rep. 2019;26(10):2720\u201337. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.015.","journal-title":"Cell Rep"},{"issue":"3","key":"722_CR116","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tem.2020.12.003","volume":"32","author":"L Zhang","year":"2021","unstructured":"Zhang L, Liu C, Jiang Q, Yin Y. Butyrate in Energy Metabolism: There Is Still More to Learn. Trends Endocrinol Metab. 2021;32(3):159\u201369. https:\/\/doi.org\/10.1016\/j.tem.2020.12.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"7075","key":"722_CR117","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484\u20139. https:\/\/doi.org\/10.1038\/nature04330.","journal-title":"Nature"},{"key":"722_CR118","doi-asserted-by":"publisher","unstructured":"Wang Z, Wang X, Fu L, Xu S, Wang X, Liao Q, Zhuang T, Liu L, Zhang H, Li W, et al. Shengmai San formula alleviates high-fat diet-induced obesity in mice through gut microbiota-derived bile acid promotion of M2 macrophage polarization and thermogenesis. Phytomedicine. 2024;133155938. https:\/\/doi.org\/10.1016\/j.phymed.2024.155938.","DOI":"10.1016\/j.phymed.2024.155938"},{"issue":"10","key":"722_CR119","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.cmet.2021.07.007","volume":"33","author":"Q Wu","year":"2021","unstructured":"Wu Q, Liang X, Wang K, Lin J, Wang X, Wang P, Zhang Y, Nie Q, Liu H, Zhang Z, et al. Intestinal hypoxia-inducible factor 2\u03b1 regulates lactate levels to shape the gut microbiome and alter thermogenesis. Cell Metab. 2021;33(10):1988\u20132003. https:\/\/doi.org\/10.1016\/j.cmet.2021.07.007.","journal-title":"Cell Metab"},{"issue":"4","key":"722_CR120","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/bf01221857","volume":"9","author":"DL Coleman","year":"1973","unstructured":"Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia. 1973;9(4):294\u20138. https:\/\/doi.org\/10.1007\/bf01221857.","journal-title":"Diabetologia"},{"issue":"6505","key":"722_CR121","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425\u201332. https:\/\/doi.org\/10.1038\/372425a0.","journal-title":"Nature"},{"issue":"8","key":"722_CR122","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s42255-021-00432-5","volume":"3","author":"M Duquenne","year":"2021","unstructured":"Duquenne M, Folgueira C, Bourouh C, Millet M, Silva A, Clasadonte J, Imbernon M, Fernandois D, Martinez-Corral I, Kusumakshi S, et al. Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function. Nat Metab. 2021;3(8):1071\u201390. https:\/\/doi.org\/10.1038\/s42255-021-00432-5.","journal-title":"Nat Metab"},{"issue":"Suppl 2","key":"722_CR123","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/2047-783x-15-s2-50","volume":"15","author":"E Gorska","year":"2010","unstructured":"Gorska E, Popko K, Stelmaszczyk-Emmel A, Ciepiela O, Kucharska A, Wasik M. Leptin receptors. Eur J Med Res. 2010;15(Suppl 2):50\u20134. https:\/\/doi.org\/10.1186\/2047-783x-15-s2-50.","journal-title":"Eur J Med Res"},{"issue":"13\u201314","key":"722_CR124","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1101\/gad.352550.124","volume":"39","author":"C Bodur","year":"2025","unstructured":"Bodur C, Duensing A, Myers MG. Molecular mechanisms and neural mediators of leptin action. Genes Dev. 2025;39(13\u201314):792\u2013807. https:\/\/doi.org\/10.1101\/gad.352550.124.","journal-title":"Genes Dev"},{"issue":"6836","key":"722_CR125","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/35078085","volume":"411","author":"MA Cowley","year":"2001","unstructured":"Cowley MA, Smart JL, Rubinstein M, Cerd\u00e1n MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411(6836):480\u20134. https:\/\/doi.org\/10.1038\/35078085.","journal-title":"Nature"},{"issue":"7702","key":"722_CR126","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-018-0049-7","volume":"556","author":"J Xu","year":"2018","unstructured":"Xu J, Bartolome CL, Low CS, Yi X, Chien CH, Wang P, Kong D. Genetic identification of leptin neural circuits in energy and glucose homeostases. Nature. 2018;556(7702):505\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0049-7.","journal-title":"Nature"},{"issue":"13","key":"722_CR127","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1016\/j.cell.2025.04.001","volume":"188","author":"MH Solheim","year":"2025","unstructured":"Solheim MH, Stroganov S, Chen W, Subagia PS, Bauder CA, Wnuk-Lipinski D, Del R\u00edo-Mart\u00edn A, Sotelo-Hitschfeld T, Beddows CA, Klemm P, et al. Hypothalamic PNOC\/NPY neurons constitute mediators of leptin-controlled energy homeostasis. Cell. 2025;188(13):3550\u201366. https:\/\/doi.org\/10.1016\/j.cell.2025.04.001.","journal-title":"Cell"},{"issue":"4","key":"722_CR128","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cmet.2014.07.022","volume":"20","author":"GT Dodd","year":"2014","unstructured":"Dodd GT, Worth AA, Nunn N, Korpal AK, Bechtold DA, Allison MB, Myers MG Jr., Statnick MA, Luckman SM. The thermogenic effect of leptin is dependent on a distinct population of prolactin-releasing peptide neurons in the dorsomedial hypothalamus. Cell Metab. 2014;20(4):639\u201349. https:\/\/doi.org\/10.1016\/j.cmet.2014.07.022.","journal-title":"Cell Metab"},{"issue":"7818","key":"722_CR129","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41586-020-2527-y","volume":"583","author":"P Wang","year":"2020","unstructured":"Wang P, Loh KH, Wu M, Morgan DA, Schneeberger M, Yu X, Chi J, Kosse C, Kim D, Rahmouni K, et al. A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue. Nature. 2020;583(7818):839\u201344. https:\/\/doi.org\/10.1038\/s41586-020-2527-y.","journal-title":"Nature"},{"issue":"1","key":"722_CR130","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41467-020-15328-3","volume":"11","author":"L Jiang","year":"2020","unstructured":"Jiang L, Su H, Wu X, Shen H, Kim MH, Li Y, Myers MG Jr., Owyang C, Rui L. Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease. Nat Commun. 2020;11(1):1517. https:\/\/doi.org\/10.1038\/s41467-020-15328-3.","journal-title":"Nat Commun"},{"issue":"3","key":"722_CR131","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2337\/db25-0388","volume":"75","author":"Y Ono","year":"2026","unstructured":"Ono Y, Kennard S, Wall BT, Ma J, Belin de Chantem\u00e8le EJ. Adipocyte Leptin Signaling Regulates Glycemia and Cardiovascular Function by Enhancing Brown Adipose Tissue Thermogenesis in Obese Male Mice. Diabetes. 2026;75(3):441\u201353. https:\/\/doi.org\/10.2337\/db25-0388.","journal-title":"Diabetes"},{"key":"722_CR132","doi-asserted-by":"publisher","first-page":"116129","DOI":"10.1016\/j.bcp.2024.116129","volume":"223","author":"V Pena-Leon","year":"2024","unstructured":"Pena-Leon V, Perez-Lois R, Villalon M, Prida E, Mu\u00f1oz-Moreno D, Fern\u00f8 J, Qui\u00f1ones M, Al-Massadi O, Seoane LM. Novel mechanisms involved in leptin sensitization in obesity. Biochem Pharmacol. 2024;223:116129. https:\/\/doi.org\/10.1016\/j.bcp.2024.116129.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"722_CR133","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12987-022-00375-3","volume":"19","author":"Y Shi","year":"2022","unstructured":"Shi Y, Kim H, Hamann CA, Rhea EM, Brunger JM, Lippmann ES. Nuclear receptor ligand screening in an iPSC-derived in vitro blood-brain barrier model identifies new contributors to leptin transport. Fluids Barriers CNS. 2022;19(1):77. https:\/\/doi.org\/10.1186\/s12987-022-00375-3.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"722_CR134","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41467-023-37169-6","volume":"14","author":"RA Saxton","year":"2023","unstructured":"Saxton RA, Caveney NA, Moya-Garzon MD, Householder KD, Rodriguez GE, Burdsall KA, Long JZ, Garcia KC. Structural insights into the mechanism of leptin receptor activation. Nat Commun. 2023;14(1):1797. https:\/\/doi.org\/10.1038\/s41467-023-37169-6.","journal-title":"Nat Commun"},{"issue":"1","key":"722_CR135","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmet.2008.12.004","volume":"9","author":"L Ozcan","year":"2009","unstructured":"Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, Myers MG Jr., Ozcan U. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009;9(1):35\u201351. https:\/\/doi.org\/10.1016\/j.cmet.2008.12.004.","journal-title":"Cell Metab"},{"issue":"4","key":"722_CR136","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmet.2024.02.007","volume":"36","author":"D Guan","year":"2024","unstructured":"Guan D, Men Y, Bartlett A, Hern\u00e1ndez MAS, Xu J, Yi X, Li HS, Kong D, Mazitschek R, Ozcan U. Central inhibition of HDAC6 re-sensitizes leptin signaling during obesity to induce profound weight loss. Cell Metab. 2024;36(4):857\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2024.02.007.","journal-title":"Cell Metab"},{"issue":"3","key":"722_CR137","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cmet.2025.01.001","volume":"37","author":"B Tan","year":"2025","unstructured":"Tan B, Hedbacker K, Kelly L, Zhang Z, Moura-Assis A, Luo JD, Rabinowitz JD, Friedman JM. A cellular and molecular basis of leptin resistance. Cell Metab. 2025;37(3):723\u201341. https:\/\/doi.org\/10.1016\/j.cmet.2025.01.001.","journal-title":"Cell Metab"},{"key":"722_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2025.10.005","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang X, Zhu Y, Sun H, Chen X, Zhao Z, Zhang N, Zhang C, Li L, Bi Y. Adipocyte-derived extracellular vesicles are key regulators of central leptin sensitivity and energy homeostasis. Cell Metab. 2025. https:\/\/doi.org\/10.1016\/j.cmet.2025.10.005.","journal-title":"Cell Metab"},{"issue":"10","key":"722_CR139","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","volume":"66","author":"DJ Drucker","year":"2023","unstructured":"Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023;66(10):1765\u201379. https:\/\/doi.org\/10.1007\/s00125-023-05906-7.","journal-title":"Diabetologia"},{"issue":"11","key":"722_CR140","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/db11-1556","volume":"61","author":"SH Lockie","year":"2012","unstructured":"Lockie SH, Heppner KM, Chaudhary N, Chabenne JR, Morgan DA, Veyrat-Durebex C, Ananthakrishnan G, Rohner-Jeanrenaud F, Drucker DJ, DiMarchi R, et al. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes. 2012;61(11):2753\u201362. https:\/\/doi.org\/10.2337\/db11-1556.","journal-title":"Diabetes"},{"issue":"10","key":"722_CR141","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.2337\/db14-0302","volume":"63","author":"D Beiroa","year":"2014","unstructured":"Beiroa D, Imbernon M, Gallego R, Senra A, Herranz D, Villarroya F, Serrano M, Fern\u00f8 J, Salvador J, Escalada J, et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes. 2014;63(10):3346\u201358. https:\/\/doi.org\/10.2337\/db14-0302.","journal-title":"Diabetes"},{"issue":"6","key":"722_CR142","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1002\/mco2.416","volume":"4","author":"K Lin","year":"2023","unstructured":"Lin K, Dong C, Zhao B, Zhou B, Yang L. Glucagon-like peptide-1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism. MedComm (2020). 2023;4(6):e416. https:\/\/doi.org\/10.1002\/mco2.416.","journal-title":"MedComm (2020)"},{"issue":"6","key":"722_CR143","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ijo.2013.162","volume":"38","author":"J van Can","year":"2014","unstructured":"van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes (Lond). 2014;38(6):784\u201393. https:\/\/doi.org\/10.1038\/ijo.2013.162.","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"722_CR144","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, Hjerpsted JB. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242\u201351. https:\/\/doi.org\/10.1111\/dom.12932.","journal-title":"Diabetes Obes Metab"},{"key":"722_CR145","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.metabol.2018.03.017","volume":"85","author":"A Basolo","year":"2018","unstructured":"Basolo A, Burkholder J, Osgood K, Graham A, Bundrick S, Frankl J, Piaggi P, Thearle MS, Krakoff J. Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial. Metabolism. 2018;85:116\u201325. https:\/\/doi.org\/10.1016\/j.metabol.2018.03.017.","journal-title":"Metabolism"},{"key":"722_CR146","doi-asserted-by":"publisher","unstructured":"Janssen LGM, Nahon KJ, Brack\u00e9 KFM, van den Broek D, Smit R, Sardjoe Mishre ASD, Koorneef LL, Martinez-Tellez B, Burakiewicz J, Kan HE, et al. Twelve weeks of exenatide treatment increases [(18)F]fluorodeoxyglucose uptake by brown adipose tissue without affecting oxidative resting energy expenditure in nondiabetic males. Metabolism. 2020;106154167. https:\/\/doi.org\/10.1016\/j.metabol.2020.154167.","DOI":"10.1016\/j.metabol.2020.154167"},{"issue":"4","key":"722_CR147","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.neuron.2017.09.042","volume":"96","author":"J Liu","year":"2017","unstructured":"Liu J, Conde K, Zhang P, Lilascharoen V, Xu Z, Lim BK, Seeley RJ, Zhu JJ, Scott MM, Pang ZP. Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-like Peptide-1 in the Paraventricular Hypothalamus. Neuron. 2017;96(4):897\u2013909. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.042.","journal-title":"Neuron"},{"issue":"1","key":"722_CR148","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2337\/db18-0729","volume":"68","author":"MK Holt","year":"2019","unstructured":"Holt MK, Richards JE, Cook DR, Brierley DI, Williams DL, Reimann F, Gribble FM, Trapp S. Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food. Diabetes. 2019;68(1):21\u201333. https:\/\/doi.org\/10.2337\/db18-0729.","journal-title":"Diabetes"},{"issue":"2","key":"722_CR149","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s42255-021-00344-4","volume":"3","author":"DI Brierley","year":"2021","unstructured":"Brierley DI, Holt MK, Singh A, de Araujo A, McDougle M, Vergara M, Afaghani MH, Lee SJ, Scott K, Maske C, et al. Central and peripheral GLP-1 systems independently suppress eating. Nat Metab. 2021;3(2):258\u201373. https:\/\/doi.org\/10.1038\/s42255-021-00344-4.","journal-title":"Nat Metab"},{"issue":"6707","key":"722_CR150","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1126\/science.adj2537","volume":"385","author":"KS Kim","year":"2024","unstructured":"Kim KS, Park JS, Hwang E, Park MJ, Shin HY, Lee YH, Kim KM, Gautron L, Godschall E, Portillo B, et al. GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans. Science. 2024;385(6707):438\u201346. https:\/\/doi.org\/10.1126\/science.adj2537.","journal-title":"Science"},{"key":"722_CR151","doi-asserted-by":"publisher","unstructured":"Chen Z, Deng X, Shi C, Jing H, Tian Y, Zhong J, Chen G, Xu Y, Luo Y, Zhu Y. GLP-1R-positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice. J Clin Invest. 2024;134(17). https:\/\/doi.org\/10.1172\/jci178239.","DOI":"10.1172\/jci178239"},{"issue":"7","key":"722_CR152","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.cmet.2025.04.018","volume":"37","author":"J Teixidor-Deulofeu","year":"2025","unstructured":"Teixidor-Deulofeu J, Blid Sk\u00f6ldheden S, Font-Giron\u00e8s F, Feje\u0161 A, Ruud J, Engstr\u00f6m Ruud L. Semaglutide effects on energy balance are mediated by Adcyap1(+) neurons in the dorsal vagal complex. Cell Metab. 2025;37(7):1530\u201346. https:\/\/doi.org\/10.1016\/j.cmet.2025.04.018.","journal-title":"Cell Metab"},{"key":"722_CR153","doi-asserted-by":"publisher","first-page":"155142","DOI":"10.1016\/j.metabol.2022.155142","volume":"129","author":"L Norton","year":"2022","unstructured":"Norton L, Shannon C, Gastaldelli A, DeFronzo RA. Insulin: The master regulator of glucose metabolism. Metabolism. 2022;129:155142. https:\/\/doi.org\/10.1016\/j.metabol.2022.155142.","journal-title":"Metabolism"},{"issue":"4","key":"722_CR154","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.tem.2013.12.004","volume":"25","author":"KL Townsend","year":"2014","unstructured":"Townsend KL, Tseng YH. Brown fat fuel utilization and thermogenesis. Trends Endocrinol Metab. 2014;25(4):168\u201377. https:\/\/doi.org\/10.1016\/j.tem.2013.12.004.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"722_CR155","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cmet.2011.06.012","volume":"14","author":"J Orava","year":"2011","unstructured":"Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, Taittonen M, Niemi T, Enerb\u00e4ck S, et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 2011;14(2):272\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2011.06.012.","journal-title":"Cell Metab"},{"issue":"6","key":"722_CR156","doi-asserted-by":"publisher","first-page":"e99772","DOI":"10.1371\/journal.pone.0099772","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Wahl R. Responses of the insulin signaling pathways in the brown adipose tissue of rats following cold exposure. PLoS ONE. 2014;9(6):e99772. https:\/\/doi.org\/10.1371\/journal.pone.0099772.","journal-title":"PLoS ONE"},{"issue":"5656","key":"722_CR157","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/272827a0","volume":"272","author":"J Havrankova","year":"1978","unstructured":"Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 1978;272(5656):827\u20139. https:\/\/doi.org\/10.1038\/272827a0.","journal-title":"Nature"},{"issue":"5487","key":"722_CR158","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Br\u00fcning","year":"2000","unstructured":"Br\u00fcning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, M\u00fcller-Wieland D, Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science. 2000;289(5487):2122\u20135. https:\/\/doi.org\/10.1126\/science.289.5487.2122.","journal-title":"Science"},{"issue":"12","key":"722_CR159","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s42255-021-00499-0","volume":"3","author":"M Porniece Kumar","year":"2021","unstructured":"Porniece Kumar M, Cremer AL, Klemm P, Steuernagel L, Sundaram S, Jais A, Hausen AC, Tao J, Secher A, Pedersen T, et al. Insulin signalling in tanycytes gates hypothalamic insulin uptake and regulation of AgRP neuron activity. Nat Metab. 2021;3(12):1662\u201379. https:\/\/doi.org\/10.1038\/s42255-021-00499-0.","journal-title":"Nat Metab"},{"issue":"7","key":"722_CR160","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00125-024-06104-9","volume":"67","author":"M Heni","year":"2024","unstructured":"Heni M. The insulin resistant brain: impact on whole-body metabolism and body fat distribution. Diabetologia. 2024;67(7):1181\u201391. https:\/\/doi.org\/10.1007\/s00125-024-06104-9.","journal-title":"Diabetologia"},{"key":"722_CR161","doi-asserted-by":"publisher","unstructured":"Dodd GT, Kim SJ, M\u00e9quinion M, Xirouchaki CE, Br\u00fcning JC, Andrews ZB, Tiganis T. Insulin signaling in AgRP neurons regulates meal size to limit glucose excursions and insulin resistance. Sci Adv. 2021;7(9). https:\/\/doi.org\/10.1126\/sciadv.abf4100.","DOI":"10.1126\/sciadv.abf4100"},{"issue":"6","key":"722_CR162","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/s2213-8587(20)30113-3","volume":"8","author":"S Kullmann","year":"2020","unstructured":"Kullmann S, Kleinridders A, Small DM, Fritsche A, H\u00e4ring HU, Preissl H, Heni M. Central nervous pathways of insulin action in the control of metabolism and food intake. Lancet Diabetes Endocrinol. 2020;8(6):524\u201334. https:\/\/doi.org\/10.1016\/s2213-8587(20)30113-3.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"722_CR163","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tem.2025.04.010","volume":"37","author":"W Chen","year":"2026","unstructured":"Chen W, Kullmann S, Rhea EM. Expanding the understanding of insulin resistance in brain and periphery. Trends Endocrinol Metab. 2026;37(1):17\u201330. https:\/\/doi.org\/10.1016\/j.tem.2025.04.010.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"722_CR164","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s42255-025-01226-9","volume":"7","author":"S Kullmann","year":"2025","unstructured":"Kullmann S, Wagner L, Hauffe R, K\u00fchnel A, Sandforth L, Veit R, Dannecker C, Machann J, Fritsche A, Stefan N, et al. A short-term, high-caloric diet has prolonged effects on brain insulin action in men. Nat Metab. 2025;7(3):469\u201377. https:\/\/doi.org\/10.1038\/s42255-025-01226-9.","journal-title":"Nat Metab"},{"issue":"12","key":"722_CR165","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.tem.2017.10.001","volume":"28","author":"BK Mani","year":"2017","unstructured":"Mani BK, Zigman JM. Ghrelin as a Survival Hormone. Trends Endocrinol Metab. 2017;28(12):843\u201354. https:\/\/doi.org\/10.1016\/j.tem.2017.10.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"722_CR166","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1021\/acs.jmedchem.1c02191","volume":"65","author":"G Giorgioni","year":"2022","unstructured":"Giorgioni G, Del Bello F, Quaglia W, Botticelli L, Cifani C, Di Micioni E, Di Micioni MV, Piergentili A. Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor. J Med Chem. 2022;65(4):3098\u2013118. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c02191.","journal-title":"J Med Chem"},{"key":"722_CR167","doi-asserted-by":"publisher","unstructured":"Shankar K, Takemi S, Gupta D, Varshney S, Mani BK, Osborne-Lawrence S, Metzger NP, Richard CP, Berglund ED, Zigman JM. Ghrelin cell-expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin. JCI Insight. 2021;6(18). https:\/\/doi.org\/10.1172\/jci.insight.146983.","DOI":"10.1172\/jci.insight.146983"},{"issue":"4","key":"722_CR168","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41574-023-00927-z","volume":"20","author":"SS Kulkarni","year":"2024","unstructured":"Kulkarni SS, Singh O, Zigman JM. The intersection between ghrelin, metabolism and circadian rhythms. Nat Rev Endocrinol. 2024;20(4):228\u201338. https:\/\/doi.org\/10.1038\/s41574-023-00927-z.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"722_CR169","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neuron.2023.10.016","volume":"112","author":"RWS Wee","year":"2024","unstructured":"Wee RWS, Mishchanchuk K, AlSubaie R, Church TW, Gold MG, MacAskill AF. Internal-state-dependent control of feeding behavior via hippocampal ghrelin signaling. Neuron. 2024;112(2):288\u2013305. https:\/\/doi.org\/10.1016\/j.neuron.2023.10.016.","journal-title":"Neuron"},{"issue":"2","key":"722_CR170","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cmet.2017.10.016","volume":"27","author":"X Ge","year":"2018","unstructured":"Ge X, Yang H, Bednarek MA, Galon-Tilleman H, Chen P, Chen M, Lichtman JS, Wang Y, Dalmas O, Yin Y, et al. LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor. Cell Metab. 2018;27(2):461\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2017.10.016.","journal-title":"Cell Metab"},{"issue":"9","key":"722_CR171","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1172\/jci125332","volume":"129","author":"BK Mani","year":"2019","unstructured":"Mani BK, Puzziferri N, He Z, Rodriguez JA, Osborne-Lawrence S, Metzger NP, Chhina N, Gaylinn B, Thorner MO, Thomas EL, et al. LEAP2 changes with body mass and food intake in humans and mice. J Clin Invest. 2019;129(9):3909\u201323. https:\/\/doi.org\/10.1172\/jci125332.","journal-title":"J Clin Invest"},{"key":"722_CR172","doi-asserted-by":"publisher","unstructured":"Bianzano S, Henrich A, Herich L, Kalsch B, Sarubbi D, Seitz F, Forst T. Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight\/obesity: Data from two Phase I, randomised, placebo-controlled studies. Metabolism. 2023;143155550. https:\/\/doi.org\/10.1016\/j.metabol.2023.155550.","DOI":"10.1016\/j.metabol.2023.155550"},{"issue":"2","key":"722_CR173","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.clnu.2020.06.014","volume":"40","author":"R Barazzoni","year":"2021","unstructured":"Barazzoni R, Gortan Cappellari G, Zanetti M, Klaus KA, Semolic A, Johnson ML, Nair KS. Higher unacylated ghrelin and insulin sensitivity following dietary restriction and weight loss in obese humans. Clin Nutr. 2021;40(2):638\u201344. https:\/\/doi.org\/10.1016\/j.clnu.2020.06.014.","journal-title":"Clin Nutr"},{"issue":"7","key":"722_CR174","doi-asserted-by":"publisher","first-page":"e11749","DOI":"10.1371\/journal.pone.0011749","volume":"5","author":"PJ Delhanty","year":"2010","unstructured":"Delhanty PJ, Sun Y, Visser JA, van Kerkwijk A, Huisman M, van Ijcken WF, Swagemakers S, Smith RG, Themmen AP, van der Lely AJ. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS ONE. 2010;5(7):e11749. https:\/\/doi.org\/10.1371\/journal.pone.0011749.","journal-title":"PLoS ONE"},{"issue":"9","key":"722_CR175","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41366-023-01327-z","volume":"47","author":"M Wolf","year":"2023","unstructured":"Wolf M, Heni M, Hennige AM, Sippel K, Cegan A, Higuita LMS, Martus P, H\u00e4ring HU, Fritsche A, Peter A. Acylated- and unacylated ghrelin during an oral glucose tolerance test in humans at risk for type 2 diabetes mellitus. Int J Obes (Lond). 2023;47(9):825\u201332. https:\/\/doi.org\/10.1038\/s41366-023-01327-z.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"722_CR176","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-pharmtox-031124-101146","volume":"65","author":"AM Chao","year":"2025","unstructured":"Chao AM, Taylor S, Moore M, Amaro A, Wadden TA. Evolving Approaches for Pharmacological Therapy of Obesity. Annu Rev Pharmacol Toxicol. 2025;65(1):169\u201389. https:\/\/doi.org\/10.1146\/annurev-pharmtox-031124-101146.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"722_CR177","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","volume":"21","author":"TD M\u00fcller","year":"2022","unstructured":"M\u00fcller TD, Bl\u00fcher M, Tsch\u00f6p MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022;21(3):201\u201323. https:\/\/doi.org\/10.1038\/s41573-021-00337-8.","journal-title":"Nat Rev Drug Discov"},{"key":"722_CR178","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2021.01.002","volume":"93","author":"L Busetto","year":"2021","unstructured":"Busetto L, Bettini S, Makaronidis J, Roberts CA, Halford JCG, Batterham RL. Mechanisms of weight regain. Eur J Intern Med. 2021;93:3\u20137. https:\/\/doi.org\/10.1016\/j.ejim.2021.01.002.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"722_CR179","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cmet.2025.03.011","volume":"37","author":"E Ravussin","year":"2025","unstructured":"Ravussin E, Sanchez-Delgado G, Martin CK, Beyl RA, Greenway FL, O\u2019Farrell LS, Roell WC, Qian HR, Li J, Nishiyama H, et al. Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation. Cell Metab. 2025;37(5):1060\u201374. https:\/\/doi.org\/10.1016\/j.cmet.2025.03.011.","journal-title":"Cell Metab"},{"issue":"1","key":"722_CR180","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","volume":"21","author":"MA Nauck","year":"2022","unstructured":"Nauck MA, D\u2019Alessio DA. Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovasc Diabetol. 2022;21(1):169. https:\/\/doi.org\/10.1186\/s12933-022-01604-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"25","key":"722_CR181","doi-asserted-by":"publisher","first-page":"eadu1589","DOI":"10.1126\/sciadv.adu1589","volume":"11","author":"T Borner","year":"2025","unstructured":"Borner T, Pataro AM, Doebley SA, Furst CD, White AD, Gao SX, Chow A, Sanchez-Navarro MJ, Ghidewon MY, Halas JG, et al. Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models. Sci Adv. 2025;11(25):eadu1589. https:\/\/doi.org\/10.1126\/sciadv.adu1589.","journal-title":"Sci Adv"},{"key":"722_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-026-00059-9","author":"A Mullard","year":"2026","unstructured":"Mullard A. FDA approves GLP-1 pill for obesity. Nat Rev Drug Discov. 2026. https:\/\/doi.org\/10.1038\/d41573-026-00059-9.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"722_CR183","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa2502081","volume":"393","author":"WT Garvey","year":"2025","unstructured":"Garvey WT, Bl\u00fcher M, Osorto Contreras CK, Davies MJ, Winning Lehmann E, Pietil\u00e4inen KH, Rubino D, Sbraccia P, Wadden T, Zeuthen N, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2025;393(7):635\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2502081.","journal-title":"N Engl J Med"},{"issue":"8040","key":"722_CR184","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41586-024-08207-0","volume":"635","author":"F Sass","year":"2024","unstructured":"Sass F, Ma T, Ekberg JH, Kirigiti M, Ure\u00f1a MG, Dollet L, Brown JM, Basse AL, Yacawych WT, Burm HB, et al. NK2R control of energy expenditure and feeding to treat metabolic diseases. Nature. 2024;635(8040):987\u20131000. https:\/\/doi.org\/10.1038\/s41586-024-08207-0.","journal-title":"Nature"},{"issue":"8014","key":"722_CR185","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41586-024-07419-8","volume":"629","author":"J Petersen","year":"2024","unstructured":"Petersen J, Ludwig MQ, Juozaityte V, Ranea-Robles P, Svendsen C, Hwang E, Kristensen AW, Fadahunsi N, Lund J, Breum AW, et al. GLP-1-directed NMDA receptor antagonism for obesity treatment. Nature. 2024;629(8014):1133\u201341. https:\/\/doi.org\/10.1038\/s41586-024-07419-8.","journal-title":"Nature"},{"issue":"7","key":"722_CR186","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2024.10816","volume":"332","author":"KA Gudzune","year":"2024","unstructured":"Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024;332(7):571\u201384. https:\/\/doi.org\/10.1001\/jama.2024.10816.","journal-title":"JAMA"},{"issue":"9123","key":"722_CR187","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0140-6736(97)11509-4","volume":"352","author":"L Sj\u00f6str\u00f6m","year":"1998","unstructured":"Sj\u00f6str\u00f6m L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet. 1998;352(9123):167\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(97)11509-4.","journal-title":"Lancet"},{"issue":"9701","key":"722_CR188","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/s0140-6736(09)61375-1","volume":"374","author":"A Astrup","year":"2009","unstructured":"Astrup A, R\u00f6ssner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009;374(9701):1606\u201316. https:\/\/doi.org\/10.1016\/s0140-6736(09)61375-1.","journal-title":"Lancet"},{"issue":"24","key":"722_CR189","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2307563.","journal-title":"N Engl J Med"},{"issue":"7","key":"722_CR190","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","volume":"30","author":"HM Colhoun","year":"2024","unstructured":"Colhoun HM, Lingvay I, Brown PM, Deanfield J, Brown-Frandsen K, Kahn SE, Plutzky J, Node K, Parkhomenko A, Ryd\u00e9n L, et al. Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial. Nat Med. 2024;30(7):2058\u201366. https:\/\/doi.org\/10.1038\/s41591-024-03015-5.","journal-title":"Nat Med"},{"issue":"11","key":"722_CR191","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183.","journal-title":"N Engl J Med"},{"issue":"19","key":"722_CR192","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med"},{"issue":"3","key":"722_CR193","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/dom.15407","volume":"26","author":"Y Li","year":"2024","unstructured":"Li Y, Cheng Z, Lu W, Li P, Jiang H, Yang J, Xu J, Zhang C, Zhang L, Wang Y, et al. Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Obes Metab. 2024;26(3):1057\u201368. https:\/\/doi.org\/10.1111\/dom.15407.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"722_CR194","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/dom.15360","volume":"26","author":"K Chen","year":"2024","unstructured":"Chen K, Chen L, Shan Z, Wang G, Qu S, Qin G, Yu X, Xin W, Hsieh TH, Mu Y. Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study. Diabetes Obes Metab. 2024;26(2):690\u20138. https:\/\/doi.org\/10.1111\/dom.15360.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"722_CR195","doi-asserted-by":"publisher","first-page":"103244","DOI":"10.4239\/wjd.v16.i5.103244","volume":"16","author":"ABM Kamrul-Hasan","year":"2025","unstructured":"Kamrul-Hasan ABM, Ganakumar V, Nagendra L, Dutta D, Islam MR, Pappachan JM. Effect of beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review and meta-analysis. World J Diabetes. 2025;16(5):103244. https:\/\/doi.org\/10.4239\/wjd.v16.i5.103244.","journal-title":"World J Diabetes"},{"key":"722_CR196","doi-asserted-by":"publisher","first-page":"1433587","DOI":"10.3389\/fphar.2024.1433587","volume":"15","author":"P Lin","year":"2024","unstructured":"Lin P, Li C, Liu Y, Sun F, Hsieh TH, Lin Z, Ma Y, Gao X, Yu Q, Cao Y. Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight\/obesity: results from a phase I clinical trial. Front Pharmacol. 2024;15:1433587. https:\/\/doi.org\/10.3389\/fphar.2024.1433587.","journal-title":"Front Pharmacol"},{"issue":"778","key":"722_CR197","doi-asserted-by":"publisher","first-page":"eadp5765","DOI":"10.1126\/scitranslmed.adp5765","volume":"16","author":"KW Sloop","year":"2024","unstructured":"Sloop KW, Cox AL, Wainscott DB, White A, Droz BA, Stutsman C, Showalter AD, Suter TM, Dunbar JD, Snider BM, et al. The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron. Sci Transl Med. 2024;16(778):eadp5765. https:\/\/doi.org\/10.1126\/scitranslmed.adp5765.","journal-title":"Sci Transl Med"},{"issue":"1","key":"722_CR198","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12933-025-02781-x","volume":"24","author":"S Wharton","year":"2025","unstructured":"Wharton S, Rosenstock J, Konige M, Lin Y, Duffin K, Wilson J, Banerjee H, Pirro V, Kazda C, Mather K. Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes. Cardiovasc Diabetol. 2025;24(1):240. https:\/\/doi.org\/10.1186\/s12933-025-02781-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"722_CR199","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s2213-8587(25)00141-x","volume":"13","author":"L Ji","year":"2025","unstructured":"Ji L, Gao L, Xue H, Tian J, Wang K, Jiang H, Huang C, Lian Q, Yuan M, Gao G, et al. Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2025;13(9):777\u201389. https:\/\/doi.org\/10.1016\/s2213-8587(25)00141-x.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"722_CR200","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.1038\/s41467-024-52353-y","volume":"15","author":"D Zhu","year":"2024","unstructured":"Zhu D, Wang W, Tong G, Ma G, Ma J, Han J, Zhang X, Liu Y, Gan S, Qin H, et al. Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial. Nat Commun. 2024;15(1):8408. https:\/\/doi.org\/10.1038\/s41467-024-52353-y.","journal-title":"Nat Commun"},{"key":"722_CR201","volume-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","author":"Setmelanotide","year":"2012","unstructured":"Setmelanotide. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"issue":"1","key":"722_CR202","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s2213-8587(24)00273-0","volume":"13","author":"J Argente","year":"2025","unstructured":"Argente J, Verge CF, Okorie U, Fennoy I, Kelsey MM, Cokkinias C, Scimia C, Lee HM, Farooqi IS. Setmelanotide in patients aged 2\u20135 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial. Lancet Diabetes Endocrinol. 2025;13(1):29\u201337. https:\/\/doi.org\/10.1016\/s2213-8587(24)00273-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"722_CR203","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/s2213-8587(20)30364-8","volume":"8","author":"K Cl\u00e9ment","year":"2020","unstructured":"Cl\u00e9ment K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020;8(12):960\u201370. https:\/\/doi.org\/10.1016\/s2213-8587(20)30364-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"15","key":"722_CR204","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMx240005","volume":"391","author":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity","year":"2024","unstructured":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391(15):1464. https:\/\/doi.org\/10.1056\/NEJMx240005.","journal-title":"N Engl J Med"},{"issue":"5","key":"722_CR205","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","volume":"392","author":"M Packer","year":"2025","unstructured":"Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, Ge J, Weerakkody GJ, Ou Y, Bunck MC, et al. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2025;392(5):427\u201337. https:\/\/doi.org\/10.1056\/NEJMoa2410027.","journal-title":"N Engl J Med"},{"issue":"24","key":"722_CR206","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMc2504728","volume":"392","author":"AK Shukla","year":"2025","unstructured":"Shukla AK, Bhavya B. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025;392(24):2492. https:\/\/doi.org\/10.1056\/NEJMc2504728.","journal-title":"N Engl J Med"},{"issue":"1","key":"722_CR207","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7570\/jomes22067","volume":"32","author":"R Sinha","year":"2023","unstructured":"Sinha R, Papamargaritis D, Sargeant JA, Davies MJ. Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management. J Obes Metab Syndr. 2023;32(1):25\u201345. https:\/\/doi.org\/10.7570\/jomes22067.","journal-title":"J Obes Metab Syndr"},{"issue":"7","key":"722_CR208","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jama.2024.9217","volume":"332","author":"L Zhao","year":"2024","unstructured":"Zhao L, Cheng Z, Lu Y, Liu M, Chen H, Zhang M, Wang R, Yuan Y, Li X. Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial. JAMA. 2024;332(7):551\u201360. https:\/\/doi.org\/10.1001\/jama.2024.9217.","journal-title":"JAMA"},{"issue":"9","key":"722_CR209","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1056\/NEJMoa2504214","volume":"393","author":"AM Jastreboff","year":"2025","unstructured":"Jastreboff AM, Ryan DH, Bays HE, Ebeling PR, Mackowski MG, Philipose N, Ross L, Liu Y, Burns CE, Abbasi SA, et al. Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial. N Engl J Med. 2025;393(9):843\u201357. https:\/\/doi.org\/10.1056\/NEJMoa2504214.","journal-title":"N Engl J Med"},{"issue":"2","key":"722_CR210","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","volume":"6","author":"MM V\u00e9niant","year":"2024","unstructured":"V\u00e9niant MM, Lu SC, Atangan L, Komorowski R, Stanislaus S, Cheng Y, Wu B, Falsey JR, Hager T, Thomas VA, et al. A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nat Metab. 2024;6(2):290\u2013303. https:\/\/doi.org\/10.1038\/s42255-023-00966-w.","journal-title":"Nat Metab"},{"key":"722_CR211","doi-asserted-by":"publisher","unstructured":"Dong W, Bai J, Yuan Q, Zhang Y, Zhang Y, Zhang Z, Yang M, Li H, Zhao Z, Jiang H. Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis. EBioMedicine. 2025;117105791. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105791.","DOI":"10.1016\/j.ebiom.2025.105791"},{"issue":"22","key":"722_CR212","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1056\/NEJMoa2411528","volume":"392","author":"L Ji","year":"2025","unstructured":"Ji L, Jiang H, Bi Y, Li H, Tian J, Liu D, Zhao Y, Qiu W, Huang C, Chen L, et al. Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight. N Engl J Med. 2025;392(22):2215\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2411528.","journal-title":"N Engl J Med"},{"issue":"1","key":"722_CR213","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1038\/s41467-023-44067-4","volume":"14","author":"L Ji","year":"2023","unstructured":"Ji L, Jiang H, Cheng Z, Qiu W, Liao L, Zhang Y, Li X, Pang S, Zhang L, Chen L, et al. A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity. Nat Commun. 2023;14(1):8289. https:\/\/doi.org\/10.1038\/s41467-023-44067-4.","journal-title":"Nat Commun"},{"issue":"3","key":"722_CR214","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00125-023-06053-9","volume":"67","author":"M Bl\u00fcher","year":"2024","unstructured":"Bl\u00fcher M, Rosenstock J, Hoefler J, Manuel R, Hennige AM. Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon\/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial. Diabetologia. 2024;67(3):470\u201382. https:\/\/doi.org\/10.1007\/s00125-023-06053-9.","journal-title":"Diabetologia"},{"issue":"5","key":"722_CR215","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jhep.2024.06.003","volume":"81","author":"EJ Lawitz","year":"2024","unstructured":"Lawitz EJ, Fraessdorf M, Neff GW, Schattenberg JM, Noureddin M, Alkhouri N, Schmid B, Andrews CP, Tak\u00e1cs I, Hussain SA, et al. Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon\/glucagon-like peptide-1 receptor dual agonist, in cirrhosis. J Hepatol. 2024;81(5):837\u201346. https:\/\/doi.org\/10.1016\/j.jhep.2024.06.003.","journal-title":"J Hepatol"},{"issue":"3","key":"722_CR216","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s2213-8587(23)00356-x","volume":"12","author":"CW le Roux","year":"2024","unstructured":"le Roux CW, Steen O, Lucas KJ, Startseva E, Unseld A, Hennige AM. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. Lancet Diabetes Endocrinol. 2024;12(3):162\u201373. https:\/\/doi.org\/10.1016\/s2213-8587(23)00356-x.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"722_CR217","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1038\/s41467-025-58680-y","volume":"16","author":"J Cao","year":"2025","unstructured":"Cao J, Belousoff MJ, Johnson RM, Keov P, Mariam Z, Deganutti G, Christopoulos G, Hick CA, Reedtz-Runge S, Glendorf T, et al. Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors. Nat Commun. 2025;16(1):3389. https:\/\/doi.org\/10.1038\/s41467-025-58680-y.","journal-title":"Nat Commun"},{"key":"722_CR218","doi-asserted-by":"publisher","unstructured":"Carvas AO, Leuthardt A, Kulka P, Lommi G, Hassan S, Coester B, Lundh S, Pers T, Secher A, Raun K, et al. Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3. EBioMedicine. 2025;118105836. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105836.","DOI":"10.1016\/j.ebiom.2025.105836"},{"issue":"10317","key":"722_CR219","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/s0140-6736(21)01751-7","volume":"398","author":"DCW Lau","year":"2021","unstructured":"Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, Pedersen SD, Pietil\u00e4inen KH, Rubino D, Batterham RL. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet. 2021;398(10317):2160\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(21)01751-7.","journal-title":"Lancet"},{"issue":"8","key":"722_CR220","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/s2213-8587(25)00092-0","volume":"13","author":"T Coskun","year":"2025","unstructured":"Coskun T, Wu Q, Schloot NC, Haupt A, Milicevic Z, Khouli C, Harris C. Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial. Lancet Diabetes Endocrinol. 2025;13(8):674\u201384. https:\/\/doi.org\/10.1016\/s2213-8587(25)00092-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10401","key":"722_CR221","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0140-6736(23)01053-x","volume":"402","author":"J Rosenstock","year":"2023","unstructured":"Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. Lancet. 2023;402(10401):529\u201344. https:\/\/doi.org\/10.1016\/s0140-6736(23)01053-x.","journal-title":"Lancet"},{"issue":"7","key":"722_CR222","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","volume":"30","author":"AJ Sanyal","year":"2024","unstructured":"Sanyal AJ, Kaplan LM, Frias JP, Brouwers B, Wu Q, Thomas MK, Harris C, Schloot NC, Du Y, Mather KJ, et al. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nat Med. 2024;30(7):2037\u201348. https:\/\/doi.org\/10.1038\/s41591-024-03018-2.","journal-title":"Nat Med"},{"key":"722_CR223","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.obpill.2024.100099","volume":"9","author":"HE Bays","year":"2024","unstructured":"Bays HE, Hsia DS, Nguyen LT, Peterson CA, Varghese ST. Effects of phentermine \/ topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study. Obes Pillars. 2024;9:100099. https:\/\/doi.org\/10.1016\/j.obpill.2024.100099.","journal-title":"Obes Pillars"},{"issue":"11","key":"722_CR224","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/oby.20584","volume":"21","author":"LJ Aronne","year":"2013","unstructured":"Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM. Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults. Obes (Silver Spring). 2013;21(11):2163\u201371. https:\/\/doi.org\/10.1002\/oby.20584.","journal-title":"Obes (Silver Spring)"},{"issue":"2","key":"722_CR225","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3945\/ajcn.111.024927","volume":"95","author":"WT Garvey","year":"2012","unstructured":"Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297\u2013308. https:\/\/doi.org\/10.3945\/ajcn.111.024927.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"722_CR226","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/oby.23152","volume":"29","author":"XG Lei","year":"2021","unstructured":"Lei XG, Ruan JQ, Lai C, Sun Z, Yang X. Efficacy and Safety of Phentermine\/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. Obes (Silver Spring). 2021;29(6):985\u201394. https:\/\/doi.org\/10.1002\/oby.23152.","journal-title":"Obes (Silver Spring)"},{"issue":"16","key":"722_CR227","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1017\/s0033291723001800","volume":"53","author":"CM Grilo","year":"2023","unstructured":"Grilo CM, Lydecker JA, Gueorguieva R. Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial. Psychol Med. 2023;53(16):7775\u201384. https:\/\/doi.org\/10.1017\/s0033291723001800.","journal-title":"Psychol Med"},{"issue":"12","key":"722_CR228","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.2337\/dc13-0234","volume":"36","author":"P Hollander","year":"2013","unstructured":"Hollander P, Gupta AK, Plodkowski R, Greenway F, Bays H, Burns C, Klassen P, Fujioka K. Effects of naltrexone sustained-release\/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022\u20139. https:\/\/doi.org\/10.2337\/dc13-0234.","journal-title":"Diabetes Care"},{"issue":"3","key":"722_CR229","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/dom.14267","volume":"23","author":"JA Mullally","year":"2021","unstructured":"Mullally JA, Chung WK, LeDuc CA, Reid TJ, Febres G, Holleran S, Ramakrishnan R, Korner J. Weight-loss response to naltrexone\/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study. Diabetes Obes Metab. 2021;23(3):850\u20133. https:\/\/doi.org\/10.1111\/dom.14267.","journal-title":"Diabetes Obes Metab"},{"issue":"7887","key":"722_CR230","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-021-04091-0","volume":"600","author":"J Balaich","year":"2021","unstructured":"Balaich J, Estrella M, Wu G, Jeffrey PD, Biswas A, Zhao L, Korennykh A, Donia MS. The human microbiome encodes resistance to the antidiabetic drug acarbose. Nature. 2021;600(7887):110\u20135. https:\/\/doi.org\/10.1038\/s41586-021-04091-0.","journal-title":"Nature"},{"issue":"1","key":"722_CR231","doi-asserted-by":"publisher","first-page":"101883","DOI":"10.1016\/j.xcrm.2024.101883","volume":"6","author":"X Li","year":"2025","unstructured":"Li X, Zheng S, Xu H, Zhang Z, Han X, Wei Y, Jin H, Du X, Xu H, Li M, et al. The direct and indirect inhibition of proinflammatory adipose tissue macrophages by acarbose in diet-induced obesity. Cell Rep Med. 2025;6(1):101883. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101883.","journal-title":"Cell Rep Med"},{"key":"722_CR232","doi-asserted-by":"publisher","DOI":"10.1002\/oby.24369","author":"U Holmb\u00e4ck","year":"2025","unstructured":"Holmb\u00e4ck U, Grud\u00e9n S, Kuusk S, Litorp H, Englund J, S\u00f6derh\u00e4ll A, Alderborn G, Forslund A. The Supportive Effect of Acarbose to Orlistat in Weight Management-A Randomized, Double-Blind, Multiarm Phase 2 Trial. Obes (Silver Spring). 2025. https:\/\/doi.org\/10.1002\/oby.24369.","journal-title":"Obes (Silver Spring)"},{"issue":"7","key":"722_CR233","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1056\/NEJMoa2502082","volume":"393","author":"MJ Davies","year":"2025","unstructured":"Davies MJ, Bajaj HS, Broholm C, Eliasen A, Garvey WT, le Roux CW, Lingvay I, Lyndgaard CB, Rosenstock J, Pedersen SD. Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes. N Engl J Med. 2025;393(7):648\u201359. https:\/\/doi.org\/10.1056\/NEJMoa2502082.","journal-title":"N Engl J Med"},{"key":"722_CR234","doi-asserted-by":"publisher","first-page":"106020","DOI":"10.1016\/j.phrs.2021.106020","volume":"175","author":"Y Kang","year":"2022","unstructured":"Kang Y, Kang X, Yang H, Liu H, Yang X, Liu Q, Tian H, Xue Y, Ren P, Kuang X, et al. Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability. Pharmacol Res. 2022;175:106020. https:\/\/doi.org\/10.1016\/j.phrs.2021.106020.","journal-title":"Pharmacol Res"},{"key":"722_CR235","doi-asserted-by":"publisher","unstructured":"Sung HK, Youn SJ, Choi Y, Eun SW, Shin SM. Body Fat Reduction Effect of Bifidobacterium breve B-3: A Randomized, Double-Blind, Placebo Comparative Clinical Trial. Nutrients. 2022;15(1). https:\/\/doi.org\/10.3390\/nu15010028.","DOI":"10.3390\/nu15010028"},{"issue":"6","key":"722_CR236","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1039\/d4fo06449f","volume":"16","author":"B Zhang","year":"2025","unstructured":"Zhang B, Qiu J, Qu Z, Xiao R, Wang L, Tian P, Zhang H, Chen W, Wang G. Bifidobacterium adolescentis FJSSZ23M10 modulates gut microbiota and metabolism to alleviate obesity through strain-specific genomic features. Food Funct. 2025;16(6):2415\u201331. https:\/\/doi.org\/10.1039\/d4fo06449f.","journal-title":"Food Funct"},{"issue":"5","key":"722_CR237","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","volume":"6","author":"HS Yoon","year":"2021","unstructured":"Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, Han D, Cha KH, Moon SH, Lee K, et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6(5):563\u201373. https:\/\/doi.org\/10.1038\/s41564-021-00880-5.","journal-title":"Nat Microbiol"},{"issue":"8","key":"722_CR238","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-019-0504-5","volume":"25","author":"C B\u00e1rcena","year":"2019","unstructured":"B\u00e1rcena C, Vald\u00e9s-Mas R, Mayoral P, Garabaya C, Durand S, Rodr\u00edguez F, Fern\u00e1ndez-Garc\u00eda MT, Salazar N, Nogacka AM, Garatachea N, et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat Med. 2019;25(8):1234\u201342. https:\/\/doi.org\/10.1038\/s41591-019-0504-5.","journal-title":"Nat Med"},{"key":"722_CR239","doi-asserted-by":"publisher","unstructured":"Liu E, Ji X, Zhou K. Akkermansia muciniphila for the prevention of Type 2 diabetes and obesity: A meta-analysis of animal studies. Nutrients. 2024;16(20). https:\/\/doi.org\/10.3390\/nu16203440.","DOI":"10.3390\/nu16203440"},{"issue":"7","key":"722_CR240","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096\u2013103. https:\/\/doi.org\/10.1038\/s41591-019-0495-2.","journal-title":"Nat Med"},{"issue":"3","key":"722_CR241","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cmet.2024.12.010","volume":"37","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu R, Chen Y, Cao Z, Liu C, Bao R, Wang Y, Huang S, Pan S, Qin L, et al. Akkermansia muciniphila supplementation in patients with overweight\/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut. Cell Metab. 2025;37(3):592\u2013605. https:\/\/doi.org\/10.1016\/j.cmet.2024.12.010.","journal-title":"Cell Metab"},{"issue":"7","key":"722_CR242","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s42255-024-01072-1","volume":"6","author":"X Li","year":"2024","unstructured":"Li X, Yang J, Zhou X, Dai C, Kong M, Xie L, Liu C, Liu Y, Li D, Ma X, et al. Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption. Nat Metab. 2024;6(7):1397\u2013414. https:\/\/doi.org\/10.1038\/s42255-024-01072-1.","journal-title":"Nat Metab"},{"issue":"3","key":"722_CR243","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s42255-024-00988-y","volume":"6","author":"H Li","year":"2024","unstructured":"Li H, Zhang L, Li J, Wu Q, Qian L, He J, Ni Y, Kovatcheva-Datchary P, Yuan R, Liu S, et al. Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota. Nat Metab. 2024;6(3):578\u201397. https:\/\/doi.org\/10.1038\/s42255-024-00988-y.","journal-title":"Nat Metab"},{"key":"722_CR244","doi-asserted-by":"publisher","unstructured":"Bush JR, Baisley J, Harding SV, Alfa MJ. Consumption of sSolnul(\u2122) resistant potato starch produces a prebiotic effect in a randomized, placebo-controlled clinical trial. Nutrients. 2023;15(7). https:\/\/doi.org\/10.3390\/nu15071582.","DOI":"10.3390\/nu15071582"},{"issue":"8042","key":"722_CR245","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-024-08165-7","volume":"636","author":"LC Hinte","year":"2024","unstructured":"Hinte LC, Castellano-Castillo D, Ghosh A, Melrose K, Gasser E, No\u00e9 F, Massier L, Dong H, Sun W, Hoffmann A, et al. Adipose tissue retains an epigenetic memory of obesity after weight loss. Nature. 2024;636(8042):457\u201365. https:\/\/doi.org\/10.1038\/s41586-024-08165-7.","journal-title":"Nature"},{"issue":"16","key":"722_CR246","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/bjsports-2022-106304","volume":"57","author":"F Recchia","year":"2023","unstructured":"Recchia F, Leung CK, Yu AP, Leung W, Yu DJ, Fong DY, Montero D, Lee CH, Wong SHS, Siu PM. Dose-response effects of exercise and caloric restriction on visceral adiposity in overweight and obese adults: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(16):1035\u201341. https:\/\/doi.org\/10.1136\/bjsports-2022-106304.","journal-title":"Br J Sports Med"},{"issue":"7","key":"722_CR247","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s42255-023-00829-4","volume":"5","author":"JW Beals","year":"2023","unstructured":"Beals JW, Kayser BD, Smith GI, Schweitzer GG, Kirbach K, Kearney ML, Yoshino J, Rahman G, Knight R, Patterson BW, et al. Dietary weight loss-induced improvements in metabolic function are enhanced by exercise in people with obesity and prediabetes. Nat Metab. 2023;5(7):1221\u201335. https:\/\/doi.org\/10.1038\/s42255-023-00829-4.","journal-title":"Nat Metab"},{"issue":"10","key":"722_CR248","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.celrep.2019.02.014","volume":"26","author":"L Geng","year":"2019","unstructured":"Geng L, Liao B, Jin L, Huang Z, Triggle CR, Ding H, Zhang J, Huang Y, Lin Z, Xu A. Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues. Cell Rep. 2019;26(10):2738\u201352. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.014.","journal-title":"Cell Rep"},{"issue":"9","key":"722_CR249","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s42255-024-01103-x","volume":"6","author":"C Ahn","year":"2024","unstructured":"Ahn C, Zhang T, Yang G, Rode T, Varshney P, Ghayur SJ, Chugh OK, Jiang H, Horowitz JF. Years of endurance exercise training remodel abdominal subcutaneous adipose tissue in adults with overweight or obesity. Nat Metab. 2024;6(9):1819\u201336. https:\/\/doi.org\/10.1038\/s42255-024-01103-x.","journal-title":"Nat Metab"},{"issue":"2","key":"722_CR250","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2337\/db13-1106","volume":"63","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi L, Zhang M, Wang X, Cui T, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63(2):514\u201325. https:\/\/doi.org\/10.2337\/db13-1106.","journal-title":"Diabetes"},{"issue":"1","key":"722_CR251","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00125-011-2304-4","volume":"55","author":"C Zhang","year":"2012","unstructured":"Zhang C, McFarlane C, Lokireddy S, Masuda S, Ge X, Gluckman PD, Sharma M, Kambadur R. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia. 2012;55(1):183\u201393. https:\/\/doi.org\/10.1007\/s00125-011-2304-4.","journal-title":"Diabetologia"},{"issue":"1","key":"722_CR252","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1038\/s41467-023-39710-z","volume":"14","author":"L Jin","year":"2023","unstructured":"Jin L, Han S, Lv X, Li X, Zhang Z, Kuang H, Chen Z, Lv CA, Peng W, Yang Z, et al. The muscle-enriched myokine Musclin impairs beige fat thermogenesis and systemic energy homeostasis via Tfr1\/PKA signaling in male mice. Nat Commun. 2023;14(1):4257. https:\/\/doi.org\/10.1038\/s41467-023-39710-z.","journal-title":"Nat Commun"},{"issue":"7915","key":"722_CR253","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-022-04828-5","volume":"606","author":"VL Li","year":"2022","unstructured":"Li VL, He Y, Contrepois K, Liu H, Kim JT, Wiggenhorn AL, Tanzo JT, Tung AS, Lyu X, Zushin PH, et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature. 2022;606(7915):785\u201390. https:\/\/doi.org\/10.1038\/s41586-022-04828-5.","journal-title":"Nature"},{"issue":"10","key":"722_CR254","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1038\/s42255-025-01377-9","volume":"7","author":"H Liu","year":"2025","unstructured":"Liu H, Li VL, Liu Q, Liu Y, Su C, Wong H, Yin N, Liu H, Fang X, McDermott KM, et al. Lac-Phe induces hypophagia by inhibiting AgRP neurons in mice. Nat Metab. 2025;7(10):2004\u201317. https:\/\/doi.org\/10.1038\/s42255-025-01377-9.","journal-title":"Nat Metab"},{"issue":"4","key":"722_CR255","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s42255-024-01018-7","volume":"6","author":"B Scott","year":"2024","unstructured":"Scott B, Day EA, O\u2019Brien KL, Scanlan J, Cromwell G, Scannail AN, McDonnell ME, Finlay DK, Lynch L. Metformin and feeding increase levels of the appetite-suppressing metabolite Lac-Phe in humans. Nat Metab. 2024;6(4):651\u20138. https:\/\/doi.org\/10.1038\/s42255-024-01018-7.","journal-title":"Nat Metab"},{"issue":"4","key":"722_CR256","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s42255-024-00999-9","volume":"6","author":"S Xiao","year":"2024","unstructured":"Xiao S, Li VL, Lyu X, Chen X, Wei W, Abbasi F, Knowles JW, Tung AS, Deng S, Tiwari G, et al. Lac-Phe mediates the effects of metformin on food intake and body weight. Nat Metab. 2024;6(4):659\u201369. https:\/\/doi.org\/10.1038\/s42255-024-00999-9.","journal-title":"Nat Metab"},{"issue":"1","key":"722_CR257","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2024.10.032","volume":"188","author":"MD Moya-Garzon","year":"2025","unstructured":"Moya-Garzon MD, Wang M, Li VL, Lyu X, Wei W, Tung AS, Raun SH, Zhao M, Coassolo L, Islam H, et al. A \u03b2-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites. Cell. 2025;188(1):175\u201386. https:\/\/doi.org\/10.1016\/j.cell.2024.10.032.","journal-title":"Cell"},{"issue":"6","key":"722_CR258","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cmet.2025.02.007","volume":"37","author":"J Chen","year":"2025","unstructured":"Chen J, Xiang J, Zhou M, Huang R, Zhang J, Cui Y, Jiang X, Li Y, Zhou R, Xin H, et al. Dietary timing enhances exercise by modulating fat-muscle crosstalk via adipocyte AMPK\u03b12 signaling. Cell Metab. 2025;37(6):1364\u201380. https:\/\/doi.org\/10.1016\/j.cmet.2025.02.007.","journal-title":"Cell Metab"},{"issue":"10","key":"722_CR259","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/d41573-020-00155-4","volume":"19","author":"S Crunkhorn","year":"2020","unstructured":"Crunkhorn S. CRISPR-engineered fat cells prevent obesity. Nat Rev Drug Discov. 2020;19(10):672. https:\/\/doi.org\/10.1038\/d41573-020-00155-4.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"722_CR260","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1038\/s41467-021-27190-y","volume":"12","author":"E Tsagkaraki","year":"2021","unstructured":"Tsagkaraki E, Nicoloro SM, DeSouza T, Solivan-Rivera J, Desai A, Lifshitz LM, Shen Y, Kelly M, Guilherme A, Henriques F, et al. CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease. Nat Commun. 2021;12(1):6931. https:\/\/doi.org\/10.1038\/s41467-021-27190-y.","journal-title":"Nat Commun"},{"issue":"1","key":"722_CR261","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/s41467-025-56755-4","volume":"16","author":"S Li","year":"2025","unstructured":"Li S, Yu J, Shen Y, Xiong B, Zhao D, Xu W, Zhang S, Guan X, Liu Y, Shan X, et al. Transdermal microneedle-assisted ultrasound-enhanced CRISPRa system to enable sono-gene therapy for obesity. Nat Commun. 2025;16(1):1499. https:\/\/doi.org\/10.1038\/s41467-025-56755-4.","journal-title":"Nat Commun"},{"issue":"6","key":"722_CR262","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cell.2025.01.017","volume":"188","author":"H Shen","year":"2025","unstructured":"Shen H, Aggarwal N, Cui B, Foo GW, He Y, Srivastava SK, Li S, Seah MZX, Wun KS, Ling H, et al. Engineered commensals for targeted nose-to-brain drug delivery. Cell. 2025;188(6):1545\u201362. https:\/\/doi.org\/10.1016\/j.cell.2025.01.017.","journal-title":"Cell"},{"issue":"8","key":"722_CR263","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.molmed.2023.04.006","volume":"29","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Di\u00e9guez C, Fern\u00f8 J, L\u00f3pez M. Obesity wars: hypothalamic sEVs a new hope. Trends Mol Med. 2023;29(8):622\u201334. https:\/\/doi.org\/10.1016\/j.molmed.2023.04.006.","journal-title":"Trends Mol Med"},{"issue":"7873","key":"722_CR264","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, \u017d\u00eddek A, Potapenko A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u20139. https:\/\/doi.org\/10.1038\/s41586-021-03819-2.","journal-title":"Nature"},{"issue":"8061","key":"722_CR265","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41586-025-08683-y","volume":"641","author":"L Coassolo","year":"2025","unstructured":"Coassolo L, N BD-S, Nguyen Q, Wiggenhorn A, Zhao M, Wang DC, Toomer D, Lone J, Wei Y, Patel A, et al. Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide. Nature. 2025;641(8061):192\u2013201. https:\/\/doi.org\/10.1038\/s41586-025-08683-y.","journal-title":"Nature"},{"issue":"4","key":"722_CR266","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13679-017-0283-6","volume":"6","author":"KL Marlatt","year":"2017","unstructured":"Marlatt KL, Ravussin E. Brown Adipose Tissue: an Update on Recent Findings. Curr Obes Rep. 2017;6(4):389\u201396. https:\/\/doi.org\/10.1007\/s13679-017-0283-6.","journal-title":"Curr Obes Rep"},{"key":"722_CR267","doi-asserted-by":"publisher","unstructured":"Martinez-Tellez B, Sch\u00f6nke M, Kovynev A, Garcia-Dominguez E, Ortiz-Alvarez L, Verhoeven A, Gacesa R, Vich Vila A, Ducarmon QR, Jimenez-Pavon D et al. Roseburia inulinivorans increases muscle strength. Gut 2026https:\/\/doi.org\/10.1136\/gutjnl-2025-336980","DOI":"10.1136\/gutjnl-2025-336980"},{"issue":"7","key":"722_CR268","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s12276-025-01462-9","volume":"57","author":"MG Kim","year":"2025","unstructured":"Kim MG, Go MJ, Kang SH, Jeong SH, Lim K. Revolutionizing CRISPR technology with artificial intelligence. Exp Mol Med. 2025;57(7):1419\u201331. https:\/\/doi.org\/10.1038\/s12276-025-01462-9.","journal-title":"Exp Mol Med"}],"updated-by":[{"DOI":"10.1007\/s13679-026-00742-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000}}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00722-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-026-00722-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00722-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:37:59Z","timestamp":1784871479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-026-00722-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":268,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1007\/s13679-026-00722-7","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this article, Drs. Qiang Lyu and Siying Weng were not set as corresponding authors, which they should have been.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13679-026-00742-3","URL":"https:\/\/doi.org\/10.1007\/s13679-026-00742-3","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"44"}}